SERPINE1 (serpin family E member 1) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: SERPINE1 (serpin family E member 1) Homo sapiens
Analyze
Symbol: SERPINE1
Name: serpin family E member 1
RGD ID: 69014
HGNC Page HGNC:8583
Description: Enables protease binding activity; serine-type endopeptidase inhibitor activity; and signaling receptor binding activity. Involved in several processes, including negative regulation of proteolysis; regulation of angiogenesis; and response to bacterium. Located in collagen-containing extracellular matrix and extracellular exosome. Part of serine protease inhibitor complex. Implicated in several diseases, including artery disease (multiple); autoimmune disease (multiple); liver disease (multiple); lung disease (multiple); and retinal vascular disease (multiple). Biomarker of several diseases, including artery disease (multiple); autoimmune disease (multiple); lung disease (multiple); retinal vascular disease (multiple); and sleep apnea (multiple).
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: endothelial plasminogen activator inhibitor; PAI; PAI-1; PAI1; PLANH1; plasminogen activator inhibitor 1; serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; serpin E1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Orthologs
More Info more info ...
Allele / Splice: See ClinVar data
Candidate Gene For: BW321_H BMD1_H
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
NCBI Annotation Information: Note: This gene has been reviewed for its involvement in coronavirus biology, and is involved in immune response or antiviral activity.
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh387101,127,104 - 101,139,247 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl7101,127,104 - 101,139,247 (+)EnsemblGRCh38hg38GRCh38
GRCh377100,770,385 - 100,782,528 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 367100,557,172 - 100,569,026 (+)NCBINCBI36Build 36hg18NCBI36
Build 347100,363,886 - 100,375,741NCBI
Celera795,778,744 - 95,790,926 (+)NCBICelera
Cytogenetic Map7q22.1NCBI
HuRef795,363,553 - 95,375,745 (+)NCBIHuRef
CHM1_17100,700,705 - 100,712,867 (+)NCBICHM1_1
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBIT2T-CHM13v2.0
CRA_TCAGchr7v27100,128,757 - 100,140,934 (+)NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
abdominal aortic aneurysm  (ISO)
Acquired Protein C Deficiency  (ISO)
Acute Lung Injury  (ISO)
acute necrotizing pancreatitis  (IEP,ISO)
adult respiratory distress syndrome  (IEP)
Aggressive Fibromatosis  (IAGP)
Albuminuria  (IEP)
alcoholic liver cirrhosis  (IAGP)
allergic rhinitis  (ISO)
amyloidosis  (IAGP)
Animal Disease Models  (EXP)
anterolateral myocardial infarction  (ISO)
aortic aneurysm  (ISO)
Aortic Remodeling  (ISO)
Arterial Thrombosis  (ISO)
asthma  (IAGP,IEP,ISO)
atherosclerosis  (EXP)
autistic disorder  (EXP)
bacterial pneumonia  (ISO)
Banti's Syndrome  (IAGP)
Behcet's disease  (EXP,IEP)
Brain Hypoxia-Ischemia  (IDA)
brain ischemia  (ISO)
breast cancer  (IEP)
bronchopulmonary dysplasia  (IEP)
Cardiac Fibrosis  (ISO)
Carotid Artery Injuries  (ISO)
Central Serous Chorioretinopathy  (IEP)
cerebral infarction  (ISO)
Chemical and Drug Induced Liver Injury  (IAGP)
cholestasis  (EXP)
Choroidal Neovascularization, Experimental  (IMP,ISO)
Chronic Allograft Nephropathy  (IEP,IMP)
chronic obstructive pulmonary disease  (IEP,ISO)
Chronic Relapsing Experimental Autoimmune Encephalomyelitis  (ISO)
congestive heart failure  (EXP)
coronary artery disease  (IAGP)
Coronavirus infectious disease  (ISS)
Dermal Fibrosis  (ISO)
diabetes mellitus  (ISO)
diabetic angiopathy  (IAGP)
Diabetic Nephropathies  (EXP,IEP,ISO)
diabetic retinopathy  (IAGP,IEP)
disseminated intravascular coagulation  (ISO)
end stage renal disease  (EXP,ISO)
Endotoxemia  (ISO)
Experimental Autoimmune Encephalomyelitis  (ISO)
Experimental Diabetes Mellitus  (EXP,ISO)
familial combined hyperlipidemia  (IEP)
familial hypercholesterolemia  (IEP)
familial Mediterranean fever  (IAGP)
Fetal Growth Retardation  (IEP)
Fever  (IAGP)
fibrosarcoma  (ISO)
focal segmental glomerulosclerosis  (EXP,ISO)
Gastrointestinal Hemorrhage  (IAGP)
glaucoma  (IEP)
glomerulonephritis  (IMP)
glomerulosclerosis  (ISO)
graft-versus-host disease  (ISO)
Graves ophthalmopathy  (IEP)
Graves' disease  (IDA,IEP)
head and neck squamous cell carcinoma  (IEP)
hematopoietic system disease  (ISO)
Hemorrhage  (IAGP,ISO)
hemorrhagic disease  (IAGP)
high grade glioma  (IEP)
Hyaline Membrane Disease  (ISO)
hypertension  (EXP,IEP,ISO)
hyperthyroidism  (IEP)
Insulin Resistance  (ISO)
interstitial lung disease  (IAGP)
Intestinal Polyps  (ISO)
Intestinal Reperfusion Injury  (ISO)
ischemic colitis  (IAGP)
Kidney Reperfusion Injury  (ISO)
limited scleroderma  (ISO)
liver cirrhosis  (IAGP)
liver disease  (EXP)
Liver Reperfusion Injury  (ISO)
lung disease  (IEP)
Lung Reperfusion Injury  (ISO)
macular degeneration  (IEP)
metabolic dysfunction and alcohol associated liver disease  (ISO)
metabolic dysfunction-associated steatotic liver disease  (IEP)
Metabolic Syndrome  (ISO)
middle cerebral artery infarction  (ISO)
Multiple Organ Failure  (ISO)
Multiple Trauma  (ISO)
muscular atrophy  (ISO)
myocardial infarction  (IAGP,ISO)
Myocardial Reperfusion Injury  (ISO)
Neointima  (IDA,ISO)
Neovascularization, Pathologic  (IEP)
nephrotic syndrome  (EXP)
nervous system disease  (EXP)
neurilemmoma  (IEP)
Noonan syndrome  (IEP)
obesity  (EXP)
obstructive sleep apnea  (IEP)
oral squamous cell carcinoma  (IEP)
Oxygen-Induced Retinopathy  (ISO)
Penetrating Wounds  (ISO)
peripheral artery disease  (IEP)
Peritoneal Adhesions  (ISO)
Peritoneal Fibrosis  (IEP)
placental insufficiency  (IEP)
Plasminogen Activator Inhibitor-1 Deficiency  (EXP,IAGP)
platelet-type bleeding disorder 10  (IEP)
pleomorphic xanthoastrocytoma  (IAGP)
pleurisy  (IAGP)
pneumonia  (IAGP,IEP)
polycystic ovary syndrome  (IEP)
polycythemia  (ISO)
polyneuropathy  (IEP)
portal vein thrombosis  (IAGP)
Postoperative Atrial Fibrillation  (IEP)
pre-eclampsia  (EXP,IEP)
Pregnancy Complications  (IAGP)
proliferative diabetic retinopathy  (IAGP,IEP)
Prostatic Neoplasms  (EXP)
pulmonary fibrosis  (IDA,ISO)
pulmonary hypertension  (IAGP,IEP,ISO)
Radiation Nephropathy  (ISO)
relapsing-remitting multiple sclerosis  (IEP)
renal fibrosis  (ISO)
respiratory allergy  (EXP)
retinal vein occlusion  (IAGP,IEP)
retinopathy of prematurity  (IDA)
rhinitis  (IAGP)
Rhinosinusitis  (IEP)
sciatic neuropathy  (ISO)
Sepsis  (IEP,ISO)
sleep apnea  (IEP)
steatotic liver disease  (EXP)
Stomach Neoplasms  (EXP)
Stroke  (IEP)
Sudden Hearing Loss  (IAGP)
systemic scleroderma  (IEP)
thoracic aortic aneurysm  (IEP)
thrombosis  (EXP,IAGP,IEP)
toxic shock syndrome  (IAGP)
transient cerebral ischemia  (ISO)
type 2 diabetes mellitus  (IAGP,IEP,ISO)
ureteral obstruction  (EXP,ISO)
urinary bladder cancer  (IDA)
uveal melanoma  (IMP)
Vascular Depression  (ISO)
Vascular Remodeling  (ISO)
Venous Thromboembolism  (IAGP)
Venous Thrombosis  (IAGP,ISO)
Ventilator-Induced Lung Injury  (ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-catechin  (EXP)
(R)-adrenaline  (ISO)
(R)-lipoic acid  (ISO)
(R)-noradrenaline  (ISO)
(S)-colchicine  (ISO)
(S)-naringenin  (ISO)
(S)-nicotine  (EXP,ISO)
1,1-dichloroethene  (ISO)
1,10-phenanthroline  (EXP)
1,2,4-trimethylbenzene  (ISO)
1,2-dimethylhydrazine  (ISO)
1-chloro-2,4-dinitrobenzene  (EXP)
1-naphthyl isothiocyanate  (EXP,ISO)
1-nitropyrene  (EXP)
15-deoxy-Delta(12,14)-prostaglandin J2  (ISO)
17alpha-ethynylestradiol  (EXP)
17beta-estradiol  (EXP,ISO)
17beta-hydroxy-17-methylestra-4,9,11-trien-3-one  (EXP)
17beta-hydroxy-5alpha-androstan-3-one  (EXP)
2,2',4,4'-Tetrabromodiphenyl ether  (EXP,ISO)
2,2,2-tetramine  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4-diaminotoluene  (ISO)
2,4-dibromophenyl 2,4,5-tribromophenyl ether  (ISO)
2,4-dichlorophenol  (EXP)
2,5-dichlorophenol  (EXP)
2,6-di-tert-butyl-4-methylphenol  (EXP)
2-amino-2-deoxy-D-galactopyranose  (ISO)
2-butoxyethanol  (ISO)
2-chloroethanol  (ISO)
2-hydroxypropanoic acid  (EXP)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (ISO)
3,3',4,4',5-pentachlorobiphenyl  (EXP,ISO)
3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid  (EXP)
3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (EXP,ISO)
3-methylcholanthrene  (EXP)
3-phenylprop-2-enal  (EXP)
4'-Methoxychalcone  (ISO)
4,4'-sulfonyldiphenol  (EXP,ISO)
4-aminophenol  (ISO)
4-hydroxy-TEMPO  (ISO)
4-nitrophenol  (ISO)
5-aza-2'-deoxycytidine  (EXP)
6-propyl-2-thiouracil  (ISO)
8-Br-cAMP  (EXP)
9-cis-retinoic acid  (EXP)
acetamide  (ISO)
acrolein  (ISO)
adenine  (ISO)
aflatoxin B1  (EXP,ISO)
aldehydo-D-glucose  (EXP,ISO)
aldosterone  (EXP,ISO)
all-trans-retinoic acid  (ISO)
Allylamine  (ISO)
aminoguanidine  (EXP,ISO)
ammonium chloride  (ISO)
amphibole asbestos  (EXP)
anthra[1,9-cd]pyrazol-6(2H)-one  (EXP,ISO)
antimonite  (EXP)
apocynin  (EXP)
arecoline  (ISO)
aristolochic acid A  (EXP)
aristolochic acids  (ISO)
arsane  (EXP)
arsenic atom  (EXP)
arsenite(3-)  (EXP,ISO)
arsenous acid  (EXP,ISO)
aspalathin  (EXP)
atazanavir sulfate  (EXP)
atorvastatin calcium  (ISO)
atrazine  (EXP,ISO)
Aurin  (EXP)
azathioprine  (EXP)
barium chloride  (ISO)
benazepril  (ISO)
benzalkonium chloride  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[b]fluoranthene  (ISO)
Benzo[k]fluoranthene  (ISO)
beta-lapachone  (EXP)
beta-naphthoflavone  (EXP,ISO)
bezafibrate  (EXP,ISO)
bicalutamide  (EXP)
bilirubin IXalpha  (EXP)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisphenol A  (EXP,ISO)
Bisphenol A diglycidyl ether  (ISO)
Bisphenol B  (EXP)
bisphenol F  (EXP,ISO)
bleomycin A2  (ISO)
bortezomib  (ISO)
busulfan  (EXP)
butan-1-ol  (EXP)
butanal  (EXP)
Butylbenzyl phthalate  (ISO)
butyric acid  (ISO)
C.I. Natural Red 20  (ISO)
cadmium atom  (EXP,ISO)
cadmium dichloride  (EXP,ISO)
cadmium selenide  (EXP)
calciol  (ISO)
calcitriol  (EXP)
calcium atom  (EXP)
calcium(0)  (EXP)
camostat  (ISO)
cannabidiol  (EXP,ISO)
cantharidin  (ISO)
capsaicin  (EXP)
captan  (ISO)
carbamazepine  (EXP)
carbofuran  (ISO)
carbon nanotube  (EXP,ISO)
carbonyl cyanide p-trifluoromethoxyphenylhydrazone  (EXP)
chenodeoxycholic acid  (EXP,ISO)
chloroform  (ISO)
chloropicrin  (EXP)
chloroquine  (EXP)
chlorpyrifos  (ISO)
choline  (EXP,ISO)
chromium(6+)  (EXP)
chrysene  (ISO)
ciglitazone  (EXP)
cis-caffeic acid  (ISO)
cisplatin  (EXP,ISO)
clofibrate  (ISO)
clofibric acid  (EXP)
Clofop  (EXP)
clothianidin  (EXP)
cobalt atom  (EXP)
cobalt dichloride  (EXP)
copper atom  (EXP)
copper(0)  (EXP)
copper(II) chloride  (EXP)
copper(II) sulfate  (EXP)
corosolic acid  (EXP)
crocidolite asbestos  (EXP,ISO)
CU-O LINKAGE  (ISO)
curcumin  (EXP,ISO)
cyanocob(III)alamin  (EXP)
cycloheximide  (EXP,ISO)
cyclophosphamide  (ISO)
cyclosporin A  (EXP,ISO)
D-glucose  (EXP,ISO)
daunorubicin  (EXP,ISO)
decabromodiphenyl ether  (ISO)
deoxycholic acid  (EXP,ISO)
dexamethasone  (EXP,ISO)
dextran sulfate  (ISO)
diarsenic trioxide  (EXP,ISO)
dibenz[a,h]anthracene  (ISO)
dibenzofuran  (ISO)
dibutyl phthalate  (ISO)
dichlorine  (ISO)
dichloroacetic acid  (ISO)
diclofenac  (EXP,ISO)
dicrotophos  (EXP)
Didecyldimethylammonium  (EXP)
dieldrin  (EXP)
dienogest  (EXP)
diethyl phthalate  (ISO)
diisobutyl phthalate  (ISO)
diisononyl phthalate  (ISO)
dinitrogen  (EXP)
dioxygen  (EXP,ISO)
dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate  (EXP)
diquat  (EXP)
dorsomorphin  (EXP)
doxorubicin  (EXP,ISO)
efavirenz  (EXP)
emodin  (EXP)
enalapril  (ISO)
enalaprilat dihydrate  (ISO)
endosulfan  (ISO)
entinostat  (EXP)
eplerenone  (ISO)
eprosartan  (ISO)
Ethyl icosapentate  (ISO)
ethyl methanesulfonate  (EXP)
famotidine  (ISO)
fenofibrate  (EXP,ISO)
fipronil  (ISO)
flutamide  (ISO)
folic acid  (EXP,ISO)
formaldehyde  (EXP)
fosinopril  (ISO)
fructose  (ISO)
fulvestrant  (EXP)
fumonisin B1  (EXP)
geldanamycin  (EXP)
gemfibrozil  (EXP)
genistein  (EXP,ISO)
gentamycin  (ISO)
gestodene  (EXP)
Gingerenone A  (EXP)
glucose  (EXP,ISO)
glycochenodeoxycholic acid  (EXP)
glycocholic acid  (EXP)
glycodeoxycholic acid  (EXP)
Goe 6976  (ISO)
gold atom  (EXP)
gold(0)  (EXP)
graphite  (ISO)
guanethidine  (ISO)
GW 501516  (EXP)
heparin  (ISO)
hexadecanoic acid  (EXP)
Hexadimethrine bromide  (ISO)
Honokiol  (ISO)
hydralazine  (ISO)
hydrochlorothiazide  (ISO)
hydrogen chloride  (ISO)
hydrogen peroxide  (EXP,ISO)
hydrogen sulfide  (ISO)
hydroxychloroquine  (EXP)
hydroxyl  (EXP)
hypochlorous acid  (ISO)
indirubin-3'-monoxime  (EXP)
indometacin  (EXP)
ionomycin  (ISO)
iron(III) citrate  (EXP)
isobutanol  (EXP)
isoprenaline  (ISO)
isorhamnetin  (EXP,ISO)
isotretinoin  (ISO)
ivermectin  (ISO)
kainic acid  (ISO)
L-ascorbic acid  (ISO)
L-methionine  (ISO)
lactacystin  (EXP)
lead diacetate  (EXP)
leflunomide  (EXP)
levonorgestrel  (EXP)
linoleic acid  (ISO)
lipoic acid  (ISO)
lipopolysaccharide  (EXP,ISO)
magnesium atom  (EXP)
magnesium dichloride  (EXP)
manganese atom  (EXP)
manganese(0)  (EXP)
manganese(II) chloride  (ISO)
mangiferin  (ISO)
Mecamylamine  (ISO)
medroxyprogesterone acetate  (EXP)
meglumine amidotrizoate  (ISO)
mercury dibromide  (EXP)
mercury dichloride  (EXP,ISO)
metaproterenol  (ISO)
metformin  (ISO)
methamphetamine  (ISO)
methapyrilene  (ISO)
methimazole  (ISO)
methotrexate  (EXP)
methyl beta-cyclodextrin  (EXP)
methyl methanesulfonate  (EXP)
methylmercury chloride  (EXP)
methylparaben  (EXP)
metyrapone  (ISO)
mifepristone  (EXP,ISO)
mitomycin C  (EXP)
mitoxantrone  (ISO)
mono(2-ethylhexyl) phthalate  (EXP)
monocrotaline  (ISO)
Muraglitazar  (ISO)
N-acetylsphingosine  (EXP)
N-methyl-N'-nitro-N-nitrosoguanidine  (ISO)
N-nitrosodiethylamine  (ISO)
N-Nitrosopyrrolidine  (EXP)
N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine  (ISO)
naphthalene  (ISO)
naphthalenes  (ISO)
nefazodone  (EXP)
nickel atom  (EXP)
nickel dichloride  (EXP,ISO)
nickel subsulfide  (EXP)
nickel sulfate  (ISO)
niclosamide  (ISO)
nicotine  (EXP,ISO)
nicotinic acid  (EXP,ISO)
nonanedioic acid  (EXP)
Nonidet P-40  (EXP)
norethisterone  (EXP)
notoginsenoside R1  (EXP,ISO)
NSC 23766  (EXP)
obeticholic acid  (EXP)
ochratoxin A  (ISO)
octadecanoic acid  (ISO)
oleic acid  (EXP)
Olmesartan medoxomil  (ISO)
orciprenaline  (ISO)
oxaliplatin  (ISO)
ozone  (EXP,ISO)
p-chloromercuribenzoic acid  (EXP)
paclitaxel  (EXP)
palbociclib  (EXP)
paracetamol  (EXP,ISO)
paraquat  (EXP,ISO)
paricalcitol  (EXP)
pazopanib  (EXP)
pentane-2,3-dione  (ISO)
Pentoxifylline  (ISO)
perfluorobutyric acid  (ISO)
perfluorohexanesulfonic acid  (ISO)
perfluorononanoic acid  (EXP)
perfluorooctane-1-sulfonic acid  (EXP,ISO)
perfluorooctanoic acid  (EXP,ISO)
perfluoropentanoic acid  (ISO)
Phenelzine  (ISO)
phenethyl isothiocyanate  (EXP)
phenformin  (ISO)
phenobarbital  (ISO)
phentolamine  (ISO)
phenylephrine  (ISO)
phenylmercury acetate  (EXP)
phenytoin  (ISO)
phorbol 13-acetate 12-myristate  (EXP,ISO)
phosgene  (ISO)
phosphane  (ISO)
phosphorus atom  (EXP)
phosphorus(.)  (EXP)
Phytolaccoside E  (EXP)
pioglitazone  (EXP,ISO)
pirfenidone  (ISO)
pirinixic acid  (EXP,ISO)
poly(I:C)  (EXP)
potassium chloride  (ISO)
potassium dichromate  (EXP)
procyanidin B3  (ISO)
progesterone  (EXP,ISO)
propanal  (EXP)
pyrrolidine dithiocarbamate  (EXP)
quercetin  (EXP)
quercetin 3-O-beta-D-glucofuranoside  (ISO)
quercetin 3-O-beta-D-glucopyranoside  (ISO)
quinolin-8-ol  (EXP)
rac-lactic acid  (EXP)
raloxifene  (EXP)
ranitidine  (ISO)
reserpine  (ISO)
resveratrol  (EXP,ISO)
rifampicin  (EXP,ISO)
rimonabant  (ISO)
rosmarinic acid  (EXP,ISO)
rotenone  (ISO)
S-butyl-DL-homocysteine (S,R)-sulfoximine  (ISO)
salvianolic acid B  (ISO)
saralasin  (ISO)
SB 203580  (ISO)
SB 431542  (EXP)
Securinine  (EXP)
serpentine asbestos  (ISO)
Shikonin  (ISO)
silicon atom  (ISO)
silicon dioxide  (EXP,ISO)
silver atom  (EXP)
silver(0)  (EXP)
simvastatin  (EXP,ISO)
sirolimus  (EXP,ISO)
sodium arsenate  (EXP)
sodium arsenite  (EXP,ISO)
sodium dichromate  (ISO)
sodium dodecyl sulfate  (EXP)
Soman  (ISO)
sotorasib  (EXP)
spironolactone  (EXP)
streptozocin  (ISO)
succimer  (ISO)
sulforaphane  (ISO)
sulindac sulfide  (EXP)
sunitinib  (EXP)
Sunset Yellow FCF  (EXP)
superoxide  (EXP)
tacrolimus hydrate  (ISO)
tamoxifen  (EXP)
tartrazine  (EXP)
taurocholic acid  (ISO)
telmisartan  (ISO)
temozolomide  (EXP)
tert-butyl hydroperoxide  (EXP)
Tesaglitazar  (ISO)
testosterone  (ISO)
tetrachloromethane  (ISO)
tetraphene  (ISO)
thiacloprid  (ISO)
thimerosal  (EXP)
thioacetamide  (ISO)
thiophanate-methyl  (ISO)
thiram  (EXP)
tibolone  (EXP)
titanium dioxide  (EXP,ISO)
topotecan  (EXP,ISO)
trametinib  (EXP)
trans-caffeic acid  (ISO)
triadimefon  (EXP)
triamterene  (ISO)
trichloroethene  (ISO)
trichostatin A  (EXP)
triclosan  (EXP)
trimellitic anhydride  (ISO)
tris(2-butoxyethyl) phosphate  (EXP)
troglitazone  (EXP,ISO)
trovafloxacin  (ISO)
undecane  (ISO)
usnic acid  (EXP)
valproic acid  (EXP,ISO)
valsartan  (EXP,ISO)
vincaleukoblastine  (EXP,ISO)
vinclozolin  (ISO)
vincristine  (EXP,ISO)
vitamin E  (ISO)
wortmannin  (EXP)
zearalenone  (EXP)
zinc atom  (EXP,ISO)
zinc molecular entity  (EXP)
zinc oxide  (ISO)
zinc pyrithione  (EXP)
zinc(0)  (EXP,ISO)
ziram  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
angiogenesis  (IEP,ISO)
cellular response to aldosterone  (ISO)
cellular response to angiotensin  (ISO)
cellular response to ATP  (ISO)
cellular response to cAMP  (ISO)
cellular response to cGMP  (ISO)
cellular response to cycloheximide  (ISO)
cellular response to dexamethasone stimulus  (ISO)
cellular response to fibroblast growth factor stimulus  (ISO)
cellular response to follicle-stimulating hormone stimulus  (ISO)
cellular response to glucagon stimulus  (ISO)
cellular response to glucose stimulus  (ISO)
cellular response to gravity  (ISO)
cellular response to growth factor stimulus  (ISO)
cellular response to hydrogen peroxide  (ISO)
cellular response to hypoxia  (ISO)
cellular response to insulin stimulus  (ISO)
cellular response to interleukin-1  (ISO)
cellular response to leukemia inhibitory factor  (ISO)
cellular response to lipopolysaccharide  (IMP,ISO)
cellular response to low-density lipoprotein particle stimulus  (ISO)
cellular response to mechanical stimulus  (ISO)
cellular response to metal ion  (ISO)
cellular response to nerve growth factor stimulus  (ISO)
cellular response to nicotine  (ISO)
cellular response to organic cyclic compound  (ISO)
cellular response to platelet-derived growth factor stimulus  (ISO)
cellular response to potassium ion  (ISO)
cellular response to resveratrol  (ISO)
cellular response to transforming growth factor beta stimulus  (ISO)
cellular response to xenobiotic stimulus  (ISO)
decidualization  (ISO)
defense response to Gram-negative bacterium  (IGI)
dentinogenesis  (IDA)
female gonad development  (ISO)
fibrinolysis  (TAS)
mast cell activation  (ISO)
negative regulation of blood coagulation  (IC)
negative regulation of cell adhesion mediated by integrin  (IDA)
negative regulation of cell migration  (IDA,ISO)
negative regulation of endopeptidase activity  (IDA,ISO)
negative regulation of endothelial cell apoptotic process  (IMP)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors  (IMP)
negative regulation of fibrinolysis  (IDA,NAS)
negative regulation of gene expression  (ISO)
negative regulation of plasminogen activation  (IBA,IDA,IMP,NAS)
negative regulation of smooth muscle cell migration  (IDA)
negative regulation of smooth muscle cell-matrix adhesion  (IDA)
negative regulation of vascular wound healing  (IBA,IGI)
negative regulation of wound healing  (IC)
placenta development  (ISO)
positive regulation of angiogenesis  (IMP,ISO)
positive regulation of blood coagulation  (IMP)
positive regulation of calcium ion import  (ISO)
positive regulation of coagulation  (ISO)
positive regulation of collagen biosynthetic process  (ISO)
positive regulation of epithelium regeneration  (ISO)
positive regulation of fibroblast proliferation  (ISO)
positive regulation of gene expression  (ISO)
positive regulation of inflammatory response  (IGI)
positive regulation of interleukin-8 production  (IMP)
positive regulation of keratinocyte migration  (ISO)
positive regulation of leukotriene production involved in inflammatory response  (IMP)
positive regulation of monocyte chemotaxis  (IMP)
positive regulation of odontoblast differentiation  (IDA)
positive regulation of receptor-mediated endocytosis  (IDA)
regulation of angiogenesis  (ISO)
regulation of cell population proliferation  (ISO)
regulation of signaling receptor activity  (IDA)
replicative senescence  (IMP)
response to cytokine  (ISO)
response to epidermal growth factor  (ISO)
response to estrogen  (ISO)
response to hyperoxia  (ISO)
response to laminar fluid shear stress  (ISO)
response to lipopolysaccharide  (ISO)
response to nutrient levels  (ISO)
response to reactive oxygen species  (ISO)
response to starvation  (ISO)
response to transforming growth factor beta  (ISO)
tissue regeneration  (ISO)

Cellular Component

Molecular Function

Molecular Pathway Annotations     Click to see Annotation Detail View
References

References - curated
# Reference Title Reference Citation
1. The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension. Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.
2. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Allaire E, etal., Circulation. 1998 Jul 21;98(3):249-55.
3. Selective inducible nitric oxide synthase inhibition attenuates organ dysfunction and elevated endothelin levels in LPS-induced DIC model rats. Asakura H, etal., J Thromb Haemost. 2005 May;3(5):1050-5.
4. Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease. Ashitani J, etal., Intern Med. 2002 Mar;41(3):181-5.
5. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. Askari AT, etal., J Exp Med. 2003 Mar 3;197(5):615-24.
6. Mutant matrix metalloproteinase-9 reduces postoperative peritoneal adhesions in rats. Atta H, etal., Int J Surg. 2016 Feb;26:58-63. doi: 10.1016/j.ijsu.2015.12.065. Epub 2016 Jan 12.
7. Four USH2A founder mutations underlie the majority of Usher syndrome type 2 cases among non-Ashkenazi Jews. Auslender N, etal., Genet Test. 2008 Jun;12(2):289-94. doi: 10.1089/gte.2007.0107.
8. Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension. Avendano MS, etal., Br J Pharmacol. 2016 May;173(9):1541-55. doi: 10.1111/bph.13457. Epub 2016 Mar 21.
9. Secretion of cardiac plasminogen activator during hypoxia-induced right ventricular hypertrophy. Bansal DD, etal., J Mol Cell Cardiol. 1997 Nov;29(11):3105-14.
10. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. Barazzone C, etal., J Clin Invest. 1996 Dec 15;98(12):2666-73.
11. Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy. Basu A, etal., Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4974-81. doi: 10.1167/iovs.09-3619. Epub 2009 May 14.
12. Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension. Bayan K, etal., J Thromb Thrombolysis. 2009 Jul;28(1):57-62. doi: 10.1007/s11239-008-0244-8. Epub 2008 Aug 7.
13. Plasminogen activator inhibitor-1 gene polymorphism in Iranian Azeri Turkish patients with FMF disease and its association with amyloidosis. Bonyadi M, etal., Eur J Pediatr. 2013 Jan;172(1):91-8. doi: 10.1007/s00431-012-1844-z. Epub 2012 Oct 5.
14. Pioglitazone in adult rats reverses immediate postnatal overfeeding-induced metabolic, hormonal, and inflammatory alterations. Boullu-Ciocca S, etal., Endocrine. 2015 Dec;50(3):608-19. doi: 10.1007/s12020-015-0657-z. Epub 2015 Jun 18.
15. Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids. Brims FJ, etal., Thorax. 2009 Dec;64(12):1037-43. Epub 2009 Aug 23.
16. Modulation of plasminogen activator inhibitor type-1 biosynthesis in vitro and in vivo with oligo(nucleoside phosphorothioate)s and related constructs. Buczko W, etal., Pharmacol Ther. 1997 Oct-Dec;76(1-3):161-75.
17. Treatment with oestrogen-receptor agonists or oxytocin in conjunction with exercise protects against post-menopausal myocardial infarction in rats. Bulut EC, etal., Exp Physiol. 2016 Mar 9. doi: 10.1113/EP085708.
18. Fructose-induced inflammation, insulin resistance and oxidative stress: A liver pathological triad effectively disrupted by lipoic acid. Castro MC, etal., Life Sci. 2015 Sep 15;137:1-6. doi: 10.1016/j.lfs.2015.07.010. Epub 2015 Jul 17.
19. Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders. Chang ML, etal., J Gastroenterol Hepatol. 2015 Feb;30(2):329-36. doi: 10.1111/jgh.12705.
20. SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin. Chang W, etal., J Biol Chem. 2010 Mar 12;285(11):8196-206. Epub 2010 Jan 8.
21. Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia. Charakida M, etal., Atherosclerosis. 2009 Jun;204(2):532-7. doi: 10.1016/j.atherosclerosis.2008.09.025. Epub 2008 Oct 5.
22. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. Chen CH, etal., J Lab Clin Med. 2003 Aug;142(2):100-5.
23. Intravesical administration of plasminogen activator inhibitor type-1 inhibits in vivo bladder tumor invasion and progression. Chen SC, etal., J Urol. 2009 Jan;181(1):336-42. Epub 2008 Nov 17.
24. Suppression of plasminogen activator inhibitor-1 by inhaled nitric oxide attenuates the adverse effects of hyperoxia in a rat model of acute lung injury. Chen Y, etal., Thromb Res. 2015 Jul;136(1):131-8. doi: 10.1016/j.thromres.2015.04.018. Epub 2015 Apr 22.
25. Association of the 4 g/5 g polymorphism of plasminogen activator inhibitor-1 gene with sudden sensorineural hearing loss. A case control study. Cho SH, etal., BMC Ear Nose Throat Disord. 2012 Jun 6;12:5. doi: 10.1186/1472-6815-12-5.
26. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma. Cosan D, etal., Genet Test Mol Biomarkers. 2009 Aug;13(4):543-6.
27. Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian population. D'Amico M, etal., Gene. 2015 Aug 15;568(1):85-8. doi: 10.1016/j.gene.2015.05.034. Epub 2015 May 16.
28. Plasminogen activator inhibitor-1 in the aqueous humor of patients with and without glaucoma. Dan J, etal., Arch Ophthalmol. 2005 Feb;123(2):220-4.
29. The prognostic value of BCAR1 in patients with primary breast cancer. Dorssers LC, etal., Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6194-202.
30. [Effects of Shensu II Recipe on the expressions of transforming growth factor-beta1, and plasminogen activator inhibitor-1 in the focal segmental glomerulosclerosis rats]. Dou YT, etal., Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Nov;31(11):1531-7.
31. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats. Du YG, etal., Chin J Integr Med. 2015 Dec 28.
32. Aortic Remodelling Is Improved by 2,3,5,4'-Tetrahydroxystilbene-2-O-beta-D-glucoside Involving the Smad3 Pathway in Spontaneously Hypertensive Rats. Duan J, etal., Evid Based Complement Alternat Med. 2015;2015:789027. doi: 10.1155/2015/789027. Epub 2015 Nov 29.
33. The role of TNF-a and PAI-1 gene polymorphisms in familial Mediterranean fever. Dundar M, etal., Mod Rheumatol. 2013 Jan;23(1):140-5. doi: 10.1007/s10165-012-0687-9. Epub 2012 Jun 27.
34. Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation. East E, etal., Neuropathol Appl Neurobiol. 2008 Apr;34(2):216-30. Epub 2007 Nov 5.
35. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia. Eissa DS and Ahmed TM, Blood Coagul Fibrinolysis. 2013 Mar;24(2):181-8. doi: 10.1097/MBC.0b013e32835b249d.
36. Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitis. El Solh AA, etal., Intensive Care Med. 2006 Jan;32(1):110-5. Epub 2005 Nov 12.
37. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Estellés A, etal., Blood. 1994 Jul 1;84(1):143-50.
38. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Ezzidi I, etal., Diabetes Metab. 2009 Jun;35(3):214-9. doi: 10.1016/j.diabet.2008.12.002. Epub 2009 May 5.
39. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Fan J, etal., Am J Respir Cell Mol Biol. 2000 Apr;22(4):412-21.
40. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Farina A, etal., Prenat Diagn. 2006 Dec;26(12):1115-20.
41. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus. Funk M, etal., Wien Klin Wochenschr. 2005 Oct;117(19-20):707-10.
42. Insertion/deletion plasminogen activator inhibitor 1 and insertion/deletion angiotensin-converting enzyme gene polymorphisms in diabetic retinopathy in type 2 diabetes. Globocnik-Petrovic M, etal., Ophthalmologica. 2003 May-Jun;217(3):219-24.
43. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Glueck CJ, etal., Clin Appl Thromb Hemost. 2005 Oct;11(4):375-89.
44. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Glueck CJ, etal., Metabolism. 2000 Jul;49(7):845-52.
45. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
46. Smad2-dependent protease nexin-1 overexpression differentiates chronic aneurysms from acute dissections of human ascending aorta. Gomez D, etal., Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2222-32. doi: 10.1161/ATVBAHA.113.301327. Epub 2013 Jun 27.
47. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors. Gong R, etal., Arthritis Rheum. 2007 May;56(5):1608-17.
48. Evidence of proatherogenic inflammation in polycystic ovary syndrome. González F, etal., Metabolism. 2009 Jul;58(7):954-62. doi: 10.1016/j.metabol.2009.02.022.
49. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels. Gori AM, etal., Thromb Haemost. 2004 Jul;92(1):54-60.
50. Combination of Ligusticum chuanxiong and Radix Paeoniae ameliorats focal cerebral ischemic in MCAO rats via endoplasmic reticulum stress-dependent apoptotic signaling pathway. Gu J, etal., J Ethnopharmacol. 2016 Apr 20. pii: S0378-8741(16)30217-3. doi: 10.1016/j.jep.2016.04.024.
51. Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease. Gurgey A, etal., Blood Coagul Fibrinolysis. 2003 Feb;14(2):121-4.
52. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Gutierrez LS, etal., Cancer Res. 2000 Oct 15;60(20):5839-47.
53. Plasminogen activator inhibitor-1 in patients with ischemic stroke. Haapaniemi E, etal., Acta Neurochir Suppl. 2000;76:277-8.
54. Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia. Haitsma JJ, etal., Eur Respir J. 2008 Dec;32(6):1599-606. doi: 10.1183/09031936.00045908. Epub 2008 Sep 3.
55. [Effect of amiloride on the pathology of a rat model of chronic obstructive pulmonary disease]. Han XD, etal., Zhonghua Jie He He Hu Xi Za Zhi. 2007 May;30(5):363-7.
56. The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling. He L, etal., Evid Based Complement Alternat Med. 2009 Aug 25.
57. Tissue-type plasminogen activator depletion affects the nasal mucosa matrix reconstruction in allergic rhinitis mice. Hua H, etal., Allergol Immunopathol (Madr). 2011 Jul-Aug;39(4):206-11. doi: 10.1016/j.aller.2010.09.010. Epub 2011 Feb 19.
58. A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. Huang Y, etal., J Clin Invest. 2003 Aug;112(3):379-88.
59. Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value. Hundsdorfer B, etal., J Craniomaxillofac Surg. 2005 Jun;33(3):191-6. Epub 2005 Apr 22.
60. Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Iijima H, etal., Am J Ophthalmol. 1999 Apr;127(4):477-8.
61. Hyperbaric oxygen therapy prevents coagulation disorders in an experimental model of multiple organ failure syndrome. Imperatore F, etal., Intensive Care Med. 2006 Nov;32(11):1881-8. Epub 2006 Sep 15.
62. Plasminogen activator inhibitor-1 and tissue-type plasminogen activator are up-regulated during unilateral ureteral obstruction in adult rats. Ishidoya S, etal., J Urol. 2002 Mar;167(3):1503-7.
63. A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia. Iversen PO, etal., Thromb Haemost. 2010 Aug;104(2):350-4. doi: 10.1160/TH09-12-0816. Epub 2010 Jun 10.
64. Effects of activated protein C on ventilator-induced lung injury in rats. Jiang JS, etal., Respiration. 2010;80(3):246-53. Epub 2010 Jan 28.
65. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-beta1-induced plasminogen activator inhibitor-1 signaling. Jung ES, etal., Nephrology (Carlton). 2016 Feb 11. doi: 10.1111/nep.12747.
66. The mRNA expressions and immunohistochemistry of factors involved in angiogenesis and lymphangiogenesis in the early stage of rat skin incision wounds. Kameyama H, etal., Leg Med (Tokyo). 2015 Jul;17(4):255-60. doi: 10.1016/j.legalmed.2015.02.007. Epub 2015 Mar 7.
67. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia. Karásek D, etal., Thromb Res. 2009;123(3):466-75. doi: 10.1016/j.thromres.2008.02.011. Epub 2008 Apr 16.
68. t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension. Katta S, etal., Indian J Hum Genet. 2008 May;14(2):37-40.
69. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor. Kenichi M, etal., J Lab Clin Med. 2004 Aug;144(2):69-77.
70. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Kietzmann T, etal., Thromb Haemost. 2003 Apr;89(4):666-73.
71. A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Kim KK, etal., Mol Med. 2003 Jan-Feb;9(1-2):52-6.
72. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1. Kimura H, etal., Kidney Int. 1998 Nov;54(5):1659-69.
73. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats. Kobayashi N, etal., J Pharmacol Exp Ther. 2002 May;301(2):459-66.
74. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension. Kouri FM, etal., Int J Biochem Cell Biol. 2008;40(9):1872-82. Epub 2008 Feb 2.
75. Plasmin system regulation in an ovalbumin-induced rat model of asthma. Kucharewicz I, etal., Int Arch Allergy Immunol. 2008;147(3):190-6. Epub 2008 Jul 2.
76. In vivo anticoagulant effect of ethyl pyruvate in endotoxemic rats. Kung CW, etal., Thromb Res. 2011 Jun;127(6):582-8. Epub 2011 Mar 10.
77. Blockade of cysteine-rich protein 61 attenuates renal inflammation and fibrosis after ischemic kidney injury. Lai CF, etal., Am J Physiol Renal Physiol. 2014 Sep 1;307(5):F581-92. doi: 10.1152/ajprenal.00670.2013. Epub 2014 Jun 11.
78. Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. Lambert V, etal., FASEB J. 2001 Apr;15(6):1021-7.
79. Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials. Lambert V, etal., Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2791-7.
80. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy. Lang H, etal., Arch Med Res. 2016 Mar 24. pii: S0188-4409(16)30002-9. doi: 10.1016/j.arcmed.2016.03.002.
81. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Laudes IJ, etal., Am J Pathol. 2002 May;160(5):1867-75.
82. Cinidium officinale and its Bioactive Compound, Butylidenephthalide, Inhibit Laser-Induced Choroidal Neovascularization in a Rat Model. Lee YM, etal., Molecules. 2015 Nov 19;20(11):20699-708. doi: 10.3390/molecules201119728.
83. Resolution of Skin Fibrosis by Neutralization of the Antifibrinolytic Function of Plasminogen Activator Inhibitor 1. Lemaire R, etal., Arthritis Rheumatol. 2016 Feb;68(2):473-83. doi: 10.1002/art.39443.
84. Differential contributions of platelets and fibrinogen to early coagulopathy in a rat model of hemorrhagic shock. Letson HL and Dobson GP, Thromb Res. 2016 Mar 7;141:58-65. doi: 10.1016/j.thromres.2016.03.007.
85. An association between the 4G polymorphism in the PAI-1 promoter and the development of aggressive fibromatosis (desmoid tumor) in familial adenomatous polyposis patients. Li CF, etal., Fam Cancer. 2007;6(1):89-95.
86. Receptor-associated protein promotes t-PA expression, reduces PAI-1 expression and improves neurorecovery after acute ischemic stroke. Li DD, etal., J Neurol Sci. 2015 Mar 15;350(1-2):84-9. doi: 10.1016/j.jns.2015.02.022. Epub 2015 Feb 17.
87. [Protection of rosiglitazone against renal interstitial lesion and its mechanism]. Lin Q, etal., Zhonghua Yi Xue Za Zhi. 2005 Jun 22;85(23):1618-24.
88. Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection. Liu X, etal., World J Gastroenterol. 2014 Dec 28;20(48):18249-59. doi: 10.3748/wjg.v20.i48.18249.
89. Basic mechanisms and regulation of fibrinolysis. Longstaff C and Kolev K, J Thromb Haemost. 2015 Jun;13 Suppl 1:S98-105. doi: 10.1111/jth.12935.
90. Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis. Lopes Barreto D, etal., Am J Kidney Dis. 2015 May;65(5):748-53. doi: 10.1053/j.ajkd.2014.10.022. Epub 2014 Dec 17.
91. Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model. Ma D, etal., Blood. 1997 Oct 1;90(7):2738-46.
92. 4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study. Madach K, etal., Crit Care. 2010;14(2):R79. Epub 2010 Apr 29.
93. Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC). Magnussen S, etal., PLoS One. 2014 Jul 7;9(7):e101895. doi: 10.1371/journal.pone.0101895. eCollection 2014.
94. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy. Mansfield MW, etal., Thromb Haemost. 1994 Jun;71(6):731-6.
95. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Margaglione M, etal., Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):152-6.
96. Do tissue plasminogen activator-plasminogen activator inhibitor-1 complexes relate to the complications of insulin-dependent diabetes mellitus? Pittsburgh Epidemiology of Diabetes Complications Study. Maser RE, etal., J Diabetes Complications. 1997 Jul-Aug;11(4):243-9.
97. Effects of combination PPARgamma agonist and angiotensin receptor blocker on glomerulosclerosis. Matsushita K, etal., Lab Invest. 2016 Mar 21. doi: 10.1038/labinvest.2016.42.
98. Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma. Matsushita M, etal., Clin Exp Immunol. 2005 Mar;139(3):429-38.
99. Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study. Mehra R, etal., Am J Respir Crit Care Med. 2010 Sep 15;182(6):826-33. Epub 2010 May 27.
100. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome. Mehta P and Parker RI, J Pediatr Hematol Oncol. 2010 Oct;32(7):532-6. doi: 10.1097/MPH.0b013e3181e0d152.
101. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample. Meigs JB, etal., Obesity (Silver Spring). 2006 May;14(5):753-8.
102. Aortic Length Changes During Abdominal Aortic Aneurysm Formation, Expansion and Stabilisation in a Rat Model. Michineau S, etal., Eur J Vasc Endovasc Surg. 2010 Jun 14.
103. Prevalence and significance of coagulation abnormalities in community-acquired pneumonia. Milbrandt EB, etal., Mol Med. 2009 Nov-Dec;15(11-12):438-45. Epub 2009 Sep 8.
104. TGF-beta1 and Serpine 1 expression changes in traumatic deep vein thrombosis. Mo JW, etal., Genet Mol Res. 2015 Oct 30;14(4):13835-42. doi: 10.4238/2015.October.29.3.
105. Long-term administration of highly purified eicosapentaenoic acid ethyl ester improves blood coagulation abnormalities and dysfunction of vascular endothelial cells in Otsuka Long-Evans Tokushima fatty rats. Mori Y, etal., Endocr J. 2003 Oct;50(5):603-11.
106. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Mutoh M, etal., Carcinogenesis. 2008 Apr;29(4):824-9. doi: 10.1093/carcin/bgn028. Epub 2008 Feb 6.
107. Plasminogen activator inhibitor type 1 up-regulation is associated with skeletal muscle atrophy and associated fibrosis. Naderi J, etal., Am J Pathol. 2009 Aug;175(2):763-71. Epub 2009 Jul 2.
108. Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats. Naito Y, etal., J Hypertens. 2003 Jun;21(6):1107-15.
109. Protective effects of vascular endothelial growth factor on intestinal epithelial apoptosis and bacterial translocation in experimental severe acute pancreatitis. Nakajima T, etal., Pancreas. 2007 May;34(4):410-6.
110. Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats. Nobukata H, etal., Metabolism. 2000 Jul;49(7):912-9.
111. Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis. Offersen BV, etal., Lung Cancer. 2007 Apr;56(1):43-50. Epub 2007 Jan 17.
112. Upregulated expression of transforming growth factor-beta, type IV collagen, and plasminogen activator inhibitor-1 mRNA are decreased after release of unilateral ureteral obstruction. Ogata Y, etal., Tohoku J Exp Med. 2002 Jul;197(3):159-68.
113. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Oikawa T, etal., Kidney Int. 1997 Jan;51(1):164-72.
114. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. Okada M, etal., FASEB J. 2001 Dec;15(14):2757-9. Epub 2001 Oct 15.
115. Role of microthrombus formation in the development of ischemia/reperfusion-induced liver injury in rats. Okajima K, etal., Thromb Haemost. 2002 Sep;88(3):473-80.
116. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
117. Elevated plasma level of plasminogen activator inhibitor-1 (PAI-1) in patients with relapsing-remitting multiple sclerosis. Onodera H, etal., Tohoku J Exp Med. 1999 Dec;189(4):259-65.
118. Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behcet's disease. Orem A, etal., Ann Rheum Dis. 1995 Sep;54(9):726-9.
119. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis. Ozbek OY, etal., Allergy Asthma Proc. 2009 Jan-Feb;30(1):41-6. Epub 2008 Dec 6.
120. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Ozcan MA, etal., Thromb Res. 2003 Jun 1;110(4):243-7.
121. Chinese tuina downregulates the elevated levels of tissue plasminogen activator in sciatic nerve injured Sprague-Dawley rats. Pan F, etal., Chin J Integr Med. 2015 May 13.
122. Effects of Kaixinjieyu, a Chinese herbal medicine preparation, on neurovascular unit dysfunction in rats with vascular depression. Pan J, etal., BMC Complement Altern Med. 2015 Aug 19;15:291. doi: 10.1186/s12906-015-0808-z.
123. Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity. Penn JS and Rajaratnam VS, Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5423-9.
124. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Penn JS, etal., Invest Ophthalmol Vis Sci. 2001 Jan;42(1):283-90.
125. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
126. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
127. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy. Pontrelli P, etal., Transplantation. 2008 Jan 15;85(1):125-34. doi: 10.1097/01.tp.0000296831.91303.9a.
128. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Prabhakaran P, etal., Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L20-8. Epub 2003 May 2.
129. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Pretorius M, etal., Circulation. 2007 Sep 11;116(11 Suppl):I1-7.
130. Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model. Qiu P, etal., J Infect Dis. 2013 Sep;208(6):978-89. doi: 10.1093/infdis/jit247. Epub 2013 Jun 3.
131. Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis. Radenkovic D, etal., Pancreas. 2004 Aug;29(2):152-6.
132. Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Renckens R, etal., Blood. 2007 Feb 15;109(4):1593-601. Epub 2006 Oct 10.
133. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma. Revelo MP, etal., Nephrol Dial Transplant. 2005 Dec;20(12):2812-9. Epub 2005 Oct 12.
134. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
135. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
136. RGD HPO Phenotype Annotation Pipeline RGD automated import pipeline for human HPO-to-gene-to-disease annotations
137. Fibrinolytic inhibitor levels and polymorphisms in Behcet disease and their association with thrombosis. Ricart JM, etal., Br J Haematol. 2008 May;141(5):716-9. doi: 10.1111/j.1365-2141.2008.07078.x. Epub 2008 Mar 12.
138. Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response. Richardson MA, etal., J Pharmacol Exp Ther. 2008 Apr;325(1):17-26. doi: 10.1124/jpet.107.130609. Epub 2008 Jan 8.
139. Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Sangle GV, etal., Endocrinology. 2010 Sep;151(9):4455-66. doi: 10.1210/en.2010-0323. Epub 2010 Jul 14.
140. 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia. Sapru A, etal., Anesthesiology. 2009 May;110(5):1086-91.
141. Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury. Sapru A, etal., Intensive Care Med. 2010 Jan;36(1):157-63. Epub 2009 Oct 24.
142. The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Sartori MT, etal., Clin Appl Thromb Hemost. 2003 Oct;9(4):299-307.
143. Local intravascular coagulation and fibrin deposition on intestinal ischemia-reperfusion in rats. Schoots IG, etal., Surgery. 2003 Apr;133(4):411-9.
144. Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Sciacca FL, etal., Clin Cancer Res. 2004 Feb 15;10(4):1312-7.
145. Increased Umbilical Cord PAI-1 Levels in Placental Insufficiency Are Associated with Fetal Hypoxia and Angiogenesis. Seferovic MD and Gupta MB, Dis Markers. 2016;2016:7124186. doi: 10.1155/2016/7124186. Epub 2016 Jan 19.
146. The expression of fibrinolytic components in chronic paranasal sinus disease. Sejima T, etal., Am J Rhinol Allergy. 2011 Jan-Feb;25(1):1-6.
147. Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats. Serrano R, etal., Am J Physiol Regul Integr Comp Physiol. 2009 Nov;297(5):R1563-9. doi: 10.1152/ajpregu.00093.2009. Epub 2009 Sep 23.
148. A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage. Simone TM, etal., Cell Signal. 2015 May;27(5):923-33. doi: 10.1016/j.cellsig.2015.01.009. Epub 2015 Jan 22.
149. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas. Sirén V, etal., Acta Neurochir (Wien). 2004 Feb;146(2):111-8. Epub 2003 Dec 22.
150. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels. Sogutlu Sari E, etal., Cutan Ocul Toxicol. 2014 Jan 22.
151. Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients. Srinivasan R, etal., Pediatr Crit Care Med. 2010 May 13.
152. Platelet activation independent of pulmonary inflammation contributes to diesel exhaust particulate-induced promotion of arterial thrombosis. Tabor CM, etal., Part Fibre Toxicol. 2016 Feb 9;13(1):6. doi: 10.1186/s12989-016-0116-x.
153. Changes in fibrinolytic parameters in male patients with type 2 (non-insulin-dependent) diabetes mellitus. Takada Y, etal., Thromb Res. 1993 Sep 1;71(5):405-15.
154. Thiamine attenuates the hypertension and metabolic abnormalities in CD36-defective SHR: uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 deficiency. Tanaka T, etal., Mol Cell Biochem. 2007 May;299(1-2):23-35.
155. Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. Tarnow L, etal., Nephrol Dial Transplant. 2000 May;15(5):625-30.
156. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Teesalu T, etal., Am J Pathol. 2001 Dec;159(6):2227-37.
157. Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril. Toblli JE, etal., Heart. 2005 Jan;91(1):80-6.
158. Effects of gabexate mesilate on coagulopathy and organ dysfunction in rats with endotoxemia: a potential use of thrombelastography in endotoxin-induced sepsis. Tsai HJ, etal., Blood Coagul Fibrinolysis. 2015 Mar;26(2):175-84. doi: 10.1097/MBC.0000000000000214.
159. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis. Tsantes AE, etal., Thromb Haemost. 2007 Jun;97(6):907-13.
160. The role of hypercoagulability in ischemic colitis. Tsimperidis AG, etal., Scand J Gastroenterol. 2015 Jul;50(7):848-55. doi: 10.3109/00365521.2015.1010568. Epub 2015 Feb 5.
161. Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Ujhelyi B, etal., Thyroid. 2012 Apr;22(4):407-14. doi: 10.1089/thy.2011.0248. Epub 2012 Mar 2.
162. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma. Urano T, etal., Jpn J Physiol. 1993;43(2):221-8.
163. Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism. Wahrenberg H, etal., Eur J Endocrinol. 2002 May;146(5):607-11.
164. The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. Wang JJ, etal., Ophthalmology. 2008 Apr;115(4):693-9. Epub 2007 Aug 2.
165. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Ware LB, etal., Crit Care Med. 2007 Aug;35(8):1821-8.
166. A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model. Witkowski P, etal., J Cardiovasc Pharmacol. 2007 Dec;50(6):633-40.
167. Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia. Wu J, etal., Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1565-70. doi: 10.1161/ATVBAHA.109.189514. Epub 2009 Jul 2.
168. Procoagulant and fibrinolytic activity after polytrauma in rat. Wu X, etal., Am J Physiol Regul Integr Comp Physiol. 2016 Feb 15;310(4):R323-9. doi: 10.1152/ajpregu.00401.2015. Epub 2015 Dec 2.
169. Downregulated expression of plasminogen activator inhibitor-1 augments myocardial neovascularization and reduces cardiomyocyte apoptosis after acute myocardial infarction. Xiang G, etal., J Am Coll Cardiol. 2005 Aug 2;46(3):536-41.
170. Resveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation. Xue H, etal., Biosci Rep. 2016 Apr 19. pii: BSR20160035.
171. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. Yamada Y, etal., N Engl J Med. 2002 Dec 12;347(24):1916-23.
172. Bactericidal/permeability-increasing protein ameliorates hypercoagulability after hemorrhagic shock. Yamashita M Thromb Res. 1997 Aug 1;87(3):323-9.
173. Effect of intra-abdominal administration of ligustrazine nanoparticles nano spray on postoperative peritoneal adhesion in rat model. Yan S, etal., J Obstet Gynaecol Res. 2015 Dec;41(12):1942-50. doi: 10.1111/jog.12807. Epub 2015 Sep 30.
174. Elevated plasma plasminogen activator inhibitor-1 in CD36 deficiency. Yanai H, etal., Diabetes Care. 2008 Oct;31(10):e72. doi: 10.2337/dc08-1228.
175. Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns. Yang D, etal., J Neurosci. 2009 Jul 8;29(27):8669-74.
176. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats. You YP J Stroke Cerebrovasc Dis. 2016 Apr;25(4):990-7. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.014. Epub 2016 Feb 3.
177. A Selective TGFbeta Ligand Trap Attenuates Pulmonary Hypertension. Yung LM, etal., Am J Respir Crit Care Med. 2016 Apr 26.
178. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Zamarron C, etal., Lung. 2008 May-Jun;186(3):151-6. Epub 2008 Mar 11.
179. [Expression of TGF-ß1 and PAI-1 in premature infants with bronchopulmonary dysplasia]. Zhang JF, etal., Zhongguo Dang Dai Er Ke Za Zhi. 2014 Aug;16(8):810-3.
180. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis. Zhang T, etal., BMC Med. 2013 Jan 2;11:1. doi: 10.1186/1741-7015-11-1.
181. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences Zhang YP and Ma JY, Beijing Da Xue Xue Bao. 2005 Oct 18;37(5):516-9.
182. siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats. Zhang YP, etal., Acta Pharmacol Sin. 2012 Jul;33(7):897-908. doi: 10.1038/aps.2012.39. Epub 2012 Jun 4.
183. An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure. Zhang ZH, etal., Sci Rep. 2016 Feb 23;6:22151. doi: 10.1038/srep22151.
184. Temporal profile of tissue plasminogen activator (tPA) and inhibitor expression after transient focal cerebral ischemia. Zhao G, etal., Neuroreport. 2003 Sep 15;14(13):1689-92.
185. Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population. Zhong ZL and Chen S, Exp Diabetes Res. 2012;2012:350852. doi: 10.1155/2012/350852. Epub 2012 Oct 14.
Additional References at PubMed
PMID:1339823   PMID:1435917   PMID:1632457   PMID:1695900   PMID:1698787   PMID:1731226   PMID:1870265   PMID:2110366   PMID:2161846   PMID:2339362   PMID:2430793   PMID:2503541  
PMID:2544876   PMID:2612914   PMID:2820474   PMID:2840665   PMID:2891140   PMID:3025016   PMID:3026837   PMID:3090045   PMID:3092219   PMID:3097076   PMID:3132455   PMID:3262512  
PMID:7479001   PMID:7521069   PMID:7522053   PMID:7523444   PMID:7552714   PMID:7592875   PMID:7892190   PMID:8344937   PMID:8455210   PMID:8508955   PMID:8607113   PMID:8626514  
PMID:8830783   PMID:8837777   PMID:9065424   PMID:9143604   PMID:9184208   PMID:9194591   PMID:9202242   PMID:9207454   PMID:9386191   PMID:9634700   PMID:10209959   PMID:10368279  
PMID:10391209   PMID:10543954   PMID:10731421   PMID:10737800   PMID:10739390   PMID:10783396   PMID:10902815   PMID:10967118   PMID:11037896   PMID:11091191   PMID:11113116   PMID:11168509  
PMID:11260416   PMID:11266465   PMID:11289708   PMID:11332466   PMID:11347834   PMID:11384978   PMID:11385207   PMID:11397722   PMID:11418606   PMID:11427204   PMID:11454529   PMID:11457466  
PMID:11457467   PMID:11485022   PMID:11522017   PMID:11525425   PMID:11558839   PMID:11592048   PMID:11734664   PMID:11738073   PMID:11748101   PMID:11776328   PMID:11780311   PMID:11796716  
PMID:11796824   PMID:11809921   PMID:11816701   PMID:11816707   PMID:11816722   PMID:11825444   PMID:11827452   PMID:11829481   PMID:11836675   PMID:11849662   PMID:11858184   PMID:11858480  
PMID:11864708   PMID:11866539   PMID:11877282   PMID:11908512   PMID:11909993   PMID:11928807   PMID:11934213   PMID:11972486   PMID:11979351   PMID:11981424   PMID:12006921   PMID:12027469  
PMID:12032637   PMID:12038776   PMID:12057695   PMID:12063175   PMID:12064834   PMID:12082592   PMID:12086154   PMID:12090757   PMID:12091343   PMID:12107743   PMID:12110504   PMID:12114510  
PMID:12123488   PMID:12123491   PMID:12124797   PMID:12140748   PMID:12141403   PMID:12167592   PMID:12181379   PMID:12187010   PMID:12218297   PMID:12223472   PMID:12353079   PMID:12353306  
PMID:12356300   PMID:12362251   PMID:12362314   PMID:12390531   PMID:12406875   PMID:12428096   PMID:12431476   PMID:12437099   PMID:12438962   PMID:12446192   PMID:12468767   PMID:12477932  
PMID:12490312   PMID:12499900   PMID:12506026   PMID:12508941   PMID:12514663   PMID:12518110   PMID:12524082   PMID:12556966   PMID:12556967   PMID:12589088   PMID:12597520   PMID:12601637  
PMID:12615788   PMID:12642587   PMID:12670745   PMID:12684636   PMID:12686544   PMID:12694086   PMID:12694180   PMID:12694181   PMID:12700666   PMID:12701125   PMID:12707042   PMID:12708473  
PMID:12709053   PMID:12716314   PMID:12719278   PMID:12734779   PMID:12743121   PMID:12745435   PMID:12748347   PMID:12761670   PMID:12783120   PMID:12801613   PMID:12802648   PMID:12808446  
PMID:12811828   PMID:12816904   PMID:12833173   PMID:12833632   PMID:12853948   PMID:12856128   PMID:12856717   PMID:12857431   PMID:12859287   PMID:12867763   PMID:12871600   PMID:12876623  
PMID:12876625   PMID:12888867   PMID:12899665   PMID:12902511   PMID:12911596   PMID:12958610   PMID:14500731   PMID:14508198   PMID:14515181   PMID:14515194   PMID:14550286   PMID:14581151  
PMID:14585904   PMID:14592559   PMID:14597244   PMID:14597935   PMID:14605330   PMID:14623266   PMID:14629464   PMID:14629474   PMID:14631138   PMID:14642005   PMID:14642142   PMID:14652637  
PMID:14653443   PMID:14656894   PMID:14668616   PMID:14669168   PMID:14675098   PMID:14699709   PMID:14706682   PMID:14718574   PMID:14742985   PMID:14744782   PMID:14746139   PMID:14769027  
PMID:14963043   PMID:14963283   PMID:14977839   PMID:14983217   PMID:14983218   PMID:14983219   PMID:14983227   PMID:15001579   PMID:15009482   PMID:15039136   PMID:15051600   PMID:15067375  
PMID:15079805   PMID:15087600   PMID:15090858   PMID:15096570   PMID:15105509   PMID:15109703   PMID:15116245   PMID:15116265   PMID:15119966   PMID:15120696   PMID:15121769   PMID:15131125  
PMID:15146197   PMID:15149846   PMID:15170393   PMID:15175025   PMID:15183748   PMID:15191349   PMID:15194475   PMID:15198928   PMID:15217907   PMID:15218974   PMID:15234427   PMID:15243126  
PMID:15292349   PMID:15300646   PMID:15309528   PMID:15313160   PMID:15315974   PMID:15321757   PMID:15328163   PMID:15333035   PMID:15333048   PMID:15351855   PMID:15353919   PMID:15372465  
PMID:15481848   PMID:15489334   PMID:15493875   PMID:15494412   PMID:15515049   PMID:15516780   PMID:15528457   PMID:15554360   PMID:15575342   PMID:15588467   PMID:15611593   PMID:15613047  
PMID:15630497   PMID:15634264   PMID:15646834   PMID:15659127   PMID:15673060   PMID:15674349   PMID:15677734   PMID:15678273   PMID:15716278   PMID:15718495   PMID:15772559   PMID:15780823  
PMID:15820782   PMID:15823189   PMID:15824541   PMID:15827742   PMID:15831288   PMID:15831362   PMID:15837947   PMID:15841306   PMID:15842353   PMID:15843979   PMID:15853774   PMID:15853833  
PMID:15869597   PMID:15869613   PMID:15879922   PMID:15885322   PMID:15886801   PMID:15905170   PMID:15907980   PMID:15915389   PMID:15916851   PMID:15920032   PMID:15935832   PMID:15935835  
PMID:15939070   PMID:15952129   PMID:15978119   PMID:15990085   PMID:15994914   PMID:16014034   PMID:16020771   PMID:16037259   PMID:16039281   PMID:16043164   PMID:16061406   PMID:16082623  
PMID:16086925   PMID:16102055   PMID:16102886   PMID:16113755   PMID:16123492   PMID:16130596   PMID:16148154   PMID:16151016   PMID:16154434   PMID:16160004   PMID:16172282   PMID:16172807  
PMID:16179568   PMID:16202290   PMID:16210568   PMID:16228848   PMID:16237647   PMID:16266514   PMID:16270643   PMID:16272158   PMID:16274483   PMID:16279946   PMID:16307159   PMID:16321247  
PMID:16331557   PMID:16353042   PMID:16356191   PMID:16365142   PMID:16369102   PMID:16395714   PMID:16409202   PMID:16409470   PMID:16423881   PMID:16424345   PMID:16444434   PMID:16456100  
PMID:16458133   PMID:16466010   PMID:16472842   PMID:16483878   PMID:16496609   PMID:16502012   PMID:16507937   PMID:16508752   PMID:16546843   PMID:16567932   PMID:16569320   PMID:16601834  
PMID:16603315   PMID:16622840   PMID:16635210   PMID:16676078   PMID:16703752   PMID:16706983   PMID:16713569   PMID:16713670   PMID:16730474   PMID:16735791   PMID:16776623   PMID:16789641  
PMID:16796899   PMID:16816071   PMID:16828203   PMID:16839401   PMID:16845248   PMID:16857194   PMID:16862142   PMID:16879222   PMID:16879223   PMID:16883539   PMID:16896567   PMID:16902162  
PMID:16914534   PMID:16926677   PMID:16931622   PMID:16938111   PMID:16945123   PMID:16963292   PMID:16998253   PMID:17005586   PMID:17006922   PMID:17018527   PMID:17036337   PMID:17044080  
PMID:17062678   PMID:17063752   PMID:17080225   PMID:17100549   PMID:17100732   PMID:17107352   PMID:17111197   PMID:17119035   PMID:17126309   PMID:17126795   PMID:17126831   PMID:17161063  
PMID:17172275   PMID:17179821   PMID:17182940   PMID:17187779   PMID:17199731   PMID:17200772   PMID:17201153   PMID:17201588   PMID:17207964   PMID:17221326   PMID:17230042   PMID:17257155  
PMID:17258797   PMID:17259369   PMID:17263760   PMID:17269998   PMID:17276980   PMID:17299841   PMID:17309181   PMID:17320454   PMID:17322633   PMID:17328891   PMID:17351368   PMID:17355798  
PMID:17356550   PMID:17379280   PMID:17388801   PMID:17397908   PMID:17408411   PMID:17433639   PMID:17456624   PMID:17467713   PMID:17473573   PMID:17473577   PMID:17495595   PMID:17513622  
PMID:17523079   PMID:17540775   PMID:17541549   PMID:17549383   PMID:17555513   PMID:17559626   PMID:17578681   PMID:17581326   PMID:17593467   PMID:17601881   PMID:17604327   PMID:17608581  
PMID:17616807   PMID:17641264   PMID:17642204   PMID:17649957   PMID:17656673   PMID:17656680   PMID:17657675   PMID:17661167   PMID:17671042   PMID:17676631   PMID:17681507   PMID:17689411  
PMID:17689414   PMID:17690487   PMID:17696882   PMID:17697137   PMID:17698217   PMID:17702963   PMID:17719307   PMID:17721610   PMID:17721742   PMID:17723126   PMID:17761618   PMID:17765897  
PMID:17786291   PMID:17804466   PMID:17877801   PMID:17882266   PMID:17884148   PMID:17890953   PMID:17895116   PMID:17899094   PMID:17903340   PMID:17922472   PMID:17932317   PMID:17934860  
PMID:17949793   PMID:17949795   PMID:17949955   PMID:17972336   PMID:17975760   PMID:17985503   PMID:17986506   PMID:17992643   PMID:18023202   PMID:18024289   PMID:18029284   PMID:18037477  
PMID:18045665   PMID:18057060   PMID:18058192   PMID:18064331   PMID:18075282   PMID:18077030   PMID:18078928   PMID:18083357   PMID:18096824   PMID:18160587   PMID:18160588   PMID:18160589  
PMID:18160600   PMID:18160602   PMID:18173921   PMID:18174166   PMID:18180317   PMID:18182031   PMID:18182917   PMID:18196271   PMID:18208536   PMID:18234320   PMID:18239151   PMID:18262228  
PMID:18263635   PMID:18276785   PMID:18278185   PMID:18284606   PMID:18285546   PMID:18289715   PMID:18296846   PMID:18307986   PMID:18318764   PMID:18344023   PMID:18358555   PMID:18362590  
PMID:18366077   PMID:18376309   PMID:18383878   PMID:18386027   PMID:18393255   PMID:18423526   PMID:18436534   PMID:18445685   PMID:18454324   PMID:18459951   PMID:18463321   PMID:18465330  
PMID:18468424   PMID:18469003   PMID:18495745   PMID:18503142   PMID:18508114   PMID:18511872   PMID:18513389   PMID:18519237   PMID:18519558   PMID:18524690   PMID:18559377   PMID:18563738  
PMID:18580060   PMID:18597060   PMID:18599586   PMID:18600083   PMID:18609532   PMID:18614541   PMID:18615155   PMID:18616803   PMID:18618228   PMID:18619429   PMID:18621614   PMID:18624608  
PMID:18646302   PMID:18658131   PMID:18662099   PMID:18665040   PMID:18674955   PMID:18683152   PMID:18700166   PMID:18714537   PMID:18720901   PMID:18722101   PMID:18725338   PMID:18728123  
PMID:18768333   PMID:18794724   PMID:18795717   PMID:18796547   PMID:18797412   PMID:18800213   PMID:18803625   PMID:18804848   PMID:18809301   PMID:18818228   PMID:18818748   PMID:18819934  
PMID:18828272   PMID:18829023   PMID:18832570   PMID:18835034   PMID:18853133   PMID:18922856   PMID:18930220   PMID:18931510   PMID:18936436   PMID:18953568   PMID:18974388   PMID:18974580  
PMID:18974842   PMID:18977990   PMID:18978303   PMID:18983502   PMID:19004141   PMID:19008959   PMID:19015166   PMID:19016004   PMID:19018779   PMID:19019335   PMID:19033264   PMID:19037965  
PMID:19050632   PMID:19052924   PMID:19056482   PMID:19061349   PMID:19066200   PMID:19072566   PMID:19080373   PMID:19082473   PMID:19085655   PMID:19088796   PMID:19110485   PMID:19117638  
PMID:19123042   PMID:19123477   PMID:19127083   PMID:19131662   PMID:19132225   PMID:19136619   PMID:19147537   PMID:19154538   PMID:19167867   PMID:19176991   PMID:19193026   PMID:19238444  
PMID:19238514   PMID:19247692   PMID:19263529   PMID:19282863   PMID:19290852   PMID:19336886   PMID:19350365   PMID:19351570   PMID:19356953   PMID:19368854   PMID:19370415   PMID:19387820  
PMID:19395327   PMID:19401121   PMID:19410276   PMID:19419975   PMID:19420105   PMID:19423540   PMID:19438580   PMID:19439404   PMID:19443353   PMID:19444746   PMID:19475533   PMID:19479237  
PMID:19483400   PMID:19487690   PMID:19492158   PMID:19500510   PMID:19501581   PMID:19513384   PMID:19521296   PMID:19523975   PMID:19526059   PMID:19527514   PMID:19536843   PMID:19540572  
PMID:19553556   PMID:19559392   PMID:19560472   PMID:19565516   PMID:19578796   PMID:19604604   PMID:19608328   PMID:19608644   PMID:19628210   PMID:19628666   PMID:19636212   PMID:19644850  
PMID:19664386   PMID:19682239   PMID:19691831   PMID:19698976   PMID:19699511   PMID:19718071   PMID:19718486   PMID:19729601   PMID:19752858   PMID:19774387   PMID:19776673   PMID:19821806  
PMID:19824427   PMID:19838007   PMID:19838435   PMID:19844663   PMID:19855083   PMID:19856137   PMID:19857655   PMID:19860767   PMID:19896127   PMID:19906129   PMID:19909951   PMID:19913121  
PMID:19916862   PMID:19923980   PMID:19924498   PMID:19929406   PMID:19933990   PMID:19934566   PMID:19942375   PMID:19942593   PMID:19948975   PMID:19956635   PMID:20005426   PMID:20006393  
PMID:20017074   PMID:20036902   PMID:20039121   PMID:20051843   PMID:20051950   PMID:20066125   PMID:20074437   PMID:20079523   PMID:20079702   PMID:20082208   PMID:20107738   PMID:20118711  
PMID:20127289   PMID:20128871   PMID:20133900   PMID:20134171   PMID:20136501   PMID:20140262   PMID:20142115   PMID:20158910   PMID:20161734   PMID:20204407   PMID:20207250   PMID:20216986  
PMID:20222049   PMID:20228065   PMID:20236028   PMID:20299979   PMID:20300183   PMID:20302034   PMID:20334849   PMID:20346360   PMID:20351105   PMID:20352162   PMID:20353610   PMID:20356416  
PMID:20371491   PMID:20374070   PMID:20385790   PMID:20392162   PMID:20392463   PMID:20406964   PMID:20425806   PMID:20428185   PMID:20435362   PMID:20438785   PMID:20447686   PMID:20452482  
PMID:20460339   PMID:20470281   PMID:20472470   PMID:20492459   PMID:20500107   PMID:20508517   PMID:20519507   PMID:20532885   PMID:20535834   PMID:20536507   PMID:20538960   PMID:20549826  
PMID:20558613   PMID:20567875   PMID:20602615   PMID:20614004   PMID:20623540   PMID:20624254   PMID:20626032   PMID:20628086   PMID:20628624   PMID:20663859   PMID:20669347   PMID:20673868  
PMID:20706793   PMID:20708412   PMID:20717043   PMID:20724304   PMID:20727996   PMID:20734064   PMID:20737565   PMID:20740581   PMID:20806116   PMID:20810696   PMID:20816667   PMID:20818488  
PMID:20818980   PMID:20822334   PMID:20827781   PMID:20838737   PMID:20856803   PMID:20886187   PMID:20923324   PMID:20926026   PMID:20931209   PMID:20959880   PMID:21034162   PMID:21037509  
PMID:21039385   PMID:21042829   PMID:21054877   PMID:21070757   PMID:21078611   PMID:21080081   PMID:21082259   PMID:21122850   PMID:21125336   PMID:21128994   PMID:21129210   PMID:21135093  
PMID:21141508   PMID:21158116   PMID:21175428   PMID:21189605   PMID:21199867   PMID:21216681   PMID:21237226   PMID:21240498   PMID:21241403   PMID:21268395   PMID:21276792   PMID:21278057  
PMID:21280127   PMID:21280128   PMID:21304999   PMID:21306344   PMID:21311952   PMID:21316840   PMID:21332339   PMID:21370208   PMID:21373825   PMID:21406565   PMID:21413876   PMID:21414238  
PMID:21450592   PMID:21459526   PMID:21478092   PMID:21478212   PMID:21490692   PMID:21501649   PMID:21512162   PMID:21515439   PMID:21524281   PMID:21530867   PMID:21545519   PMID:21606492  
PMID:21624046   PMID:21642818   PMID:21647848   PMID:21689370   PMID:21697084   PMID:21702998   PMID:21707474   PMID:21719525   PMID:21725041   PMID:21744990   PMID:21752301   PMID:21761413  
PMID:21819560   PMID:21823537   PMID:21846428   PMID:21849906   PMID:21850503   PMID:21873635   PMID:21878476   PMID:21878751   PMID:21885611   PMID:21900343   PMID:21911891   PMID:21947232  
PMID:21968503   PMID:21975339   PMID:21989445   PMID:21993838   PMID:21996594   PMID:22011808   PMID:22055623   PMID:22064653   PMID:22088447   PMID:22099705   PMID:22100658   PMID:22106856  
PMID:22108519   PMID:22133274   PMID:22134139   PMID:22158046   PMID:22171322   PMID:22198637   PMID:22200807   PMID:22240314   PMID:22258825   PMID:22283974   PMID:22331587   PMID:22334677  
PMID:22354580   PMID:22361338   PMID:22389473   PMID:22390401   PMID:22410565   PMID:22432640   PMID:22449964   PMID:22459021   PMID:22466984   PMID:22467324   PMID:22479620   PMID:22491740  
PMID:22496752   PMID:22503724   PMID:22512572   PMID:22516898   PMID:22527222   PMID:22552687   PMID:22566702   PMID:22572461   PMID:22577291   PMID:22578058   PMID:22592924   PMID:22613596  
PMID:22653645   PMID:22740034   PMID:22740053   PMID:22745374   PMID:22747686   PMID:22771216   PMID:22798504   PMID:22803111   PMID:22809141   PMID:22819264   PMID:22819712   PMID:22850480  
PMID:22882325   PMID:22909576   PMID:22952991   PMID:22982001   PMID:22984202   PMID:22990020   PMID:22995304   PMID:23052060   PMID:23111469   PMID:23179239   PMID:23180602   PMID:23184207  
PMID:23218127   PMID:23222167   PMID:23259783   PMID:23280079   PMID:23283030   PMID:23289804   PMID:23291383   PMID:23324247   PMID:23382992   PMID:23429214   PMID:23437240   PMID:23438482  
PMID:23445116   PMID:23457639   PMID:23461356   PMID:23519427   PMID:23521508   PMID:23536951   PMID:23541763   PMID:23589033   PMID:23639427   PMID:23685140   PMID:23685927   PMID:23728617  
PMID:23770264   PMID:23790781   PMID:23835737   PMID:23856555   PMID:23859635   PMID:23871496   PMID:23873179   PMID:23898067   PMID:23898913   PMID:23903286   PMID:23979707   PMID:23988121  
PMID:23990179   PMID:23991099   PMID:24101699   PMID:24114008   PMID:24135164   PMID:24172014   PMID:24189965   PMID:24197654   PMID:24200683   PMID:24212262   PMID:24223881   PMID:24223897  
PMID:24247078   PMID:24248324   PMID:24249316   PMID:24254894   PMID:24297881   PMID:24345290   PMID:24355042   PMID:24373352   PMID:24375485   PMID:24382103   PMID:24386152   PMID:24410881  
PMID:24415745   PMID:24435163   PMID:24435452   PMID:24435552   PMID:24438928   PMID:24439532   PMID:24464915   PMID:24472072   PMID:24484533   PMID:24485402   PMID:24496159   PMID:24500480  
PMID:24503185   PMID:24532105   PMID:24578379   PMID:24596353   PMID:24610082   PMID:24619821   PMID:24623722   PMID:24648800   PMID:24651693   PMID:24651925   PMID:24695040   PMID:24702949  
PMID:24707477   PMID:24715181   PMID:24749249   PMID:24752775   PMID:24770328   PMID:24783193   PMID:24825926   PMID:24833884   PMID:24850450   PMID:24877154   PMID:24905330   PMID:24918969  
PMID:24955483   PMID:24964508   PMID:24987792   PMID:25001244   PMID:25035980   PMID:25078885   PMID:25081365   PMID:25113642   PMID:25122721   PMID:25131348   PMID:25170877   PMID:25193405  
PMID:25219833   PMID:25231632   PMID:25250948   PMID:25284719   PMID:25288465   PMID:25304332   PMID:25306554   PMID:25306598   PMID:25323935   PMID:25337248   PMID:25341237   PMID:25350781  
PMID:25378411   PMID:25386620   PMID:25416956   PMID:25450536   PMID:25489981   PMID:25501306   PMID:25509642   PMID:25554417   PMID:25558663   PMID:25558689   PMID:25618585   PMID:25631074  
PMID:25648892   PMID:25672133   PMID:25673011   PMID:25674766   PMID:25675617   PMID:25679759   PMID:25687870   PMID:25731152   PMID:25743687   PMID:25775950   PMID:25788758   PMID:25796943  
PMID:25808697   PMID:25862335   PMID:25932922   PMID:25947084   PMID:25994573   PMID:26002716   PMID:26027394   PMID:26032256   PMID:26036781   PMID:26050228   PMID:26066833   PMID:26070447  
PMID:26116962   PMID:26117986   PMID:26215730   PMID:26228839   PMID:26245493   PMID:26258650   PMID:26273123   PMID:26275833   PMID:26322636   PMID:26324706   PMID:26335051   PMID:26340801  
PMID:26345945   PMID:26359694   PMID:26406963   PMID:26434837   PMID:26451494   PMID:26460070   PMID:26504024   PMID:26537299   PMID:26540464   PMID:26548921   PMID:26559247   PMID:26616527  
PMID:26632165   PMID:26637413   PMID:26643086   PMID:26658948   PMID:26676222   PMID:26714278   PMID:26733586   PMID:26742513   PMID:26813008   PMID:26817521   PMID:26847059   PMID:26884864  
PMID:26896607   PMID:26944191   PMID:26979769   PMID:27001121   PMID:27004408   PMID:27022914   PMID:27046084   PMID:27073968   PMID:27131585   PMID:27145077   PMID:27197170   PMID:27212010  
PMID:27212082   PMID:27272255   PMID:27321098   PMID:27357063   PMID:27385000   PMID:27387503   PMID:27416303   PMID:27456456   PMID:27459171   PMID:27556405   PMID:27598010   PMID:27636933  
PMID:27697752   PMID:27713627   PMID:27759037   PMID:27796029   PMID:27805237   PMID:27819307   PMID:27856929   PMID:27861608   PMID:27893784   PMID:27941685   PMID:27959430   PMID:27975070  
PMID:27975104   PMID:28005267   PMID:28085526   PMID:28088270   PMID:28132883   PMID:28135035   PMID:28145780   PMID:28186689   PMID:28193577   PMID:28211612   PMID:28213977   PMID:28229167  
PMID:28258374   PMID:28296156   PMID:28303356   PMID:28306198   PMID:28322572   PMID:28327460   PMID:28347810   PMID:28356730   PMID:28378522   PMID:28395596   PMID:28429105   PMID:28460568  
PMID:28466654   PMID:28506312   PMID:28513507   PMID:28543872   PMID:28550093   PMID:28561456   PMID:28599907   PMID:28603947   PMID:28625976   PMID:28633683   PMID:28685212   PMID:28692480  
PMID:28747729   PMID:28758928   PMID:28771291   PMID:28777103   PMID:28821477   PMID:28838342   PMID:28857040   PMID:28858863   PMID:28882880   PMID:28899878   PMID:28913669   PMID:28924605  
PMID:28931364   PMID:28952223   PMID:28954632   PMID:28975405   PMID:28988111   PMID:29049169   PMID:29111023   PMID:29123322   PMID:29152572   PMID:29253845   PMID:29261514   PMID:29350496  
PMID:29377268   PMID:29483508   PMID:29592859   PMID:29601121   PMID:29605018   PMID:29627522   PMID:29644896   PMID:29693741   PMID:29736094   PMID:29802992   PMID:29908999   PMID:29930084  
PMID:29938477   PMID:30160528   PMID:30301460   PMID:30334491   PMID:30371230   PMID:30429105   PMID:30442055   PMID:30463014   PMID:30548470   PMID:30597502   PMID:30602990   PMID:30646864  
PMID:30669988   PMID:30670154   PMID:30718260   PMID:30743272   PMID:30799135   PMID:30833792   PMID:30937621   PMID:30953603   PMID:31002598   PMID:31023101   PMID:31061324   PMID:31064214  
PMID:31127138   PMID:31268630   PMID:31288156   PMID:31307406   PMID:31315131   PMID:31324722   PMID:31356402   PMID:31424646   PMID:31428858   PMID:31472244   PMID:31530188   PMID:31536960  
PMID:31574527   PMID:31591377   PMID:31625370   PMID:31637872   PMID:31640087   PMID:31687051   PMID:31695760   PMID:31701558   PMID:31710121   PMID:31711127   PMID:31724495   PMID:31792055  
PMID:31806394   PMID:31829037   PMID:31920171   PMID:31948344   PMID:31982478   PMID:32001531   PMID:32001608   PMID:32035284   PMID:32104682   PMID:32113686   PMID:32170551   PMID:32199904  
PMID:32205015   PMID:32217514   PMID:32281291   PMID:32296183   PMID:32301223   PMID:32399796   PMID:32422114   PMID:32570732   PMID:32633259   PMID:32657780   PMID:32683889   PMID:32811735  
PMID:32815912   PMID:32826331   PMID:32898274   PMID:32915403   PMID:32921106   PMID:32989965   PMID:32993026   PMID:33000256   PMID:33022573   PMID:33053339   PMID:33064893   PMID:33141390  
PMID:33311557   PMID:33327353   PMID:33345392   PMID:33367928   PMID:33432099   PMID:33432417   PMID:33439236   PMID:33465109   PMID:33475534   PMID:33496742   PMID:33510345   PMID:33512745  
PMID:33555692   PMID:33673196   PMID:33683668   PMID:33735891   PMID:33779113   PMID:33780362   PMID:33799903   PMID:33800359   PMID:33813081   PMID:33820852   PMID:33845483   PMID:33857223  
PMID:33893843   PMID:33946071   PMID:33961781   PMID:33998175   PMID:34015274   PMID:34019258   PMID:34042331   PMID:34110636   PMID:34187551   PMID:34195849   PMID:34273240   PMID:34290311  
PMID:34325549   PMID:34369600   PMID:34429017   PMID:34521295   PMID:34552126   PMID:34592988   PMID:34666996   PMID:34732716   PMID:34741085   PMID:34798692   PMID:34845645   PMID:34946835  
PMID:35013218   PMID:35021249   PMID:35113965   PMID:35226442   PMID:35235351   PMID:35238278   PMID:35337019   PMID:35409173   PMID:35439403   PMID:35475537   PMID:35593950   PMID:35662090  
PMID:35681461   PMID:35696571   PMID:35778962   PMID:35831314   PMID:35842542   PMID:36028501   PMID:36044519   PMID:36065507   PMID:36168721   PMID:36191254   PMID:36215168   PMID:36233135  
PMID:36244648   PMID:36257408   PMID:36433943   PMID:36522166   PMID:36526897   PMID:36632749   PMID:36639375   PMID:36646603   PMID:36681663   PMID:36697459   PMID:36755247   PMID:36841712  
PMID:36889376   PMID:36902377   PMID:36907506   PMID:36981754   PMID:37151884   PMID:37169126   PMID:37175749   PMID:37318594   PMID:37369886   PMID:37408236   PMID:37415190   PMID:37439338  
PMID:37531026   PMID:37545924   PMID:37566086   PMID:37577872   PMID:37662480   PMID:37758806   PMID:37758852   PMID:37859283   PMID:38057822   PMID:38073374   PMID:38103082   PMID:38216379  
PMID:38251423   PMID:38266576   PMID:38287534   PMID:38299390   PMID:38393683   PMID:38608056   PMID:38758826   PMID:38777211   PMID:38779680   PMID:38864767   PMID:38868940   PMID:38945485  
PMID:39238192   PMID:39281671   PMID:39337713   PMID:39467628  


Genomics

Comparative Map Data
SERPINE1
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh387101,127,104 - 101,139,247 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl7101,127,104 - 101,139,247 (+)EnsemblGRCh38hg38GRCh38
GRCh377100,770,385 - 100,782,528 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 367100,557,172 - 100,569,026 (+)NCBINCBI36Build 36hg18NCBI36
Build 347100,363,886 - 100,375,741NCBI
Celera795,778,744 - 95,790,926 (+)NCBICelera
Cytogenetic Map7q22.1NCBI
HuRef795,363,553 - 95,375,745 (+)NCBIHuRef
CHM1_17100,700,705 - 100,712,867 (+)NCBICHM1_1
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBIT2T-CHM13v2.0
CRA_TCAGchr7v27100,128,757 - 100,140,934 (+)NCBI
Serpine1
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm395137,090,358 - 137,101,126 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl5137,090,358 - 137,101,122 (-)EnsemblGRCm39 Ensembl
GRCm385137,061,504 - 137,072,272 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl5137,061,504 - 137,072,268 (-)EnsemblGRCm38mm10GRCm38
MGSCv375137,537,374 - 137,548,142 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv365137,346,135 - 137,356,886 (-)NCBIMGSCv36mm8
Celera5134,078,340 - 134,089,224 (-)NCBICelera
Cytogenetic Map5G2NCBI
cM Map576.16NCBI
Serpine1
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81225,237,977 - 25,248,356 (+)NCBIGRCr8
mRatBN7.21219,601,272 - 19,611,657 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1219,601,272 - 19,611,657 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1220,739,113 - 20,749,506 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01221,351,819 - 21,362,213 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01220,416,358 - 20,426,756 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01222,641,104 - 22,651,482 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1222,641,104 - 22,651,482 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01224,653,385 - 24,663,763 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41220,931,996 - 20,942,374 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11220,921,607 - 20,931,986 (-)NCBI
Celera1221,377,028 - 21,387,410 (+)NCBICelera
RH 3.4 Map12277.5RGD
Cytogenetic Map12q12NCBI
Serpine1
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495545616,145,944 - 16,157,142 (-)EnsemblChiLan1.0
ChiLan1.0NW_00495545616,147,523 - 16,157,040 (-)NCBIChiLan1.0ChiLan1.0
SERPINE1
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v26119,139,033 - 119,151,584 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan17167,403,992 - 167,416,224 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0793,267,517 - 93,279,728 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.17106,511,539 - 106,518,605 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl7106,510,130 - 106,518,450 (+)Ensemblpanpan1.1panPan2
SERPINE1
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.168,719,547 - 8,727,160 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl68,720,825 - 8,726,301 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha610,418,147 - 10,423,482 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.068,538,810 - 8,546,429 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl68,540,391 - 8,550,490 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.168,500,159 - 8,505,509 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.068,470,611 - 8,475,963 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.068,635,341 - 8,640,693 (-)NCBIUU_Cfam_GSD_1.0
Serpine1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024409344132,997,052 - 133,003,714 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365431,032,794 - 1,039,123 (+)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049365431,032,543 - 1,040,956 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
SERPINE1
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl38,863,695 - 8,871,547 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.138,863,738 - 8,871,572 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
SERPINE1
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.12812,047,520 - 12,060,662 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl2812,047,529 - 12,060,202 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_0236660704,295,672 - 4,308,796 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Serpine1
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_00462474016,128,059 - 16,137,337 (-)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_00462474016,128,145 - 16,136,696 (-)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in SERPINE1
111 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
NM_000602.5(SERPINE1):c.699_700del (p.Tyr233_Thr234insTer) microsatellite Congenital plasminogen activator inhibitor type 1 deficiency [RCV000014539] Chr7:101132066..101132067 [GRCh38]
Chr7:100775347..100775348 [GRCh37]
Chr7:7q22.1
pathogenic
NM_000602.4(SERPINE1):c.-820_-817G(4_5) duplication Transcription level of plasminogen activator inhibitor 1 [RCV000014540] Chr7:101126426 [GRCh38]
Chr7:100769707 [GRCh37]
Chr7:7q22.1
pathogenic|other
NM_000602.5(SERPINE1):c.43G>A (p.Ala15Thr) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000014541]|SERPINE1-related disorder [RCV003982840]|Susceptibility to severe coronavirus disease (COVID-19) due to an impaired coagulation process [RCV001807002]|not provided [RCV001723567]|not specified [RCV001530150] Chr7:101128436 [GRCh38]
Chr7:100771717 [GRCh37]
Chr7:7q22.1
pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance
GRCh38/hg38 7p22.3-q36.3(chr7:53985-159282531)x1 copy number loss See cases [RCV000052250] Chr7:53985..159282531 [GRCh38]
Chr7:53985..159075220 [GRCh37]
Chr7:149068..158767981 [NCBI36]
Chr7:7p22.3-q36.3
pathogenic
GRCh38/hg38 7q21.3-22.1(chr7:98288474-101259804)x3 copy number gain See cases [RCV000053573] Chr7:98288474..101259804 [GRCh38]
Chr7:97917786..100903085 [GRCh37]
Chr7:97755722..100689805 [NCBI36]
Chr7:7q21.3-22.1
pathogenic
GRCh38/hg38 7q22.1(chr7:100419914-102482826)x1 copy number loss See cases [RCV000054155] Chr7:100419914..102482826 [GRCh38]
Chr7:100017537..102123273 [GRCh37]
Chr7:99855473..101910278 [NCBI36]
Chr7:7q22.1
pathogenic
NM_000602.5(SERPINE1):c.1001-2A>G single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001292750] Chr7:101135713 [GRCh38]
Chr7:100778994 [GRCh37]
Chr7:7q22.1
pathogenic
NM_000602.5(SERPINE1):c.357G>T (p.Ala119=) single nucleotide variant not provided [RCV001310584] Chr7:101130506 [GRCh38]
Chr7:100773787 [GRCh37]
Chr7:7q22.1
likely benign
GRCh38/hg38 7p22.3-q36.3(chr7:54185-159282390)x1 copy number loss See cases [RCV000135401] Chr7:54185..159282390 [GRCh38]
Chr7:54185..159075079 [GRCh37]
Chr7:149268..158767840 [NCBI36]
Chr7:7p22.3-q36.3
pathogenic
GRCh38/hg38 7q22.1(chr7:99195836-102258175)x1 copy number loss See cases [RCV000135782] Chr7:99195836..102258175 [GRCh38]
Chr7:98793459..101718950 [GRCh37]
Chr7:98631395..101688175 [NCBI36]
Chr7:7q22.1
pathogenic|uncertain significance
GRCh38/hg38 7q21.3-36.3(chr7:97419852-158923762)x3 copy number gain See cases [RCV000136717] Chr7:97419852..158923762 [GRCh38]
Chr7:97049164..158716453 [GRCh37]
Chr7:96887100..158409214 [NCBI36]
Chr7:7q21.3-36.3
pathogenic
GRCh38/hg38 7q22.1(chr7:101130561-101255628)x3 copy number gain See cases [RCV000136835] Chr7:101130561..101255628 [GRCh38]
Chr7:100773842..100898909 [GRCh37]
Chr7:100560562..100685629 [NCBI36]
Chr7:7q22.1
benign
GRCh38/hg38 7q22.1(chr7:99932610-102473188)x3 copy number gain See cases [RCV000138109] Chr7:99932610..102473188 [GRCh38]
Chr7:99530233..102113635 [GRCh37]
Chr7:99368169..101900640 [NCBI36]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1295C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000286074] Chr7:101138737 [GRCh38]
Chr7:100782018 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1186C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000279284]|not provided [RCV004712306] Chr7:101138628 [GRCh38]
Chr7:100781909 [GRCh37]
Chr7:7q22.1
benign|likely benign
NM_000602.5(SERPINE1):c.*690T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000302268]|not provided [RCV004712303] Chr7:101138132 [GRCh38]
Chr7:100781413 [GRCh37]
Chr7:7q22.1
benign|likely benign
NM_000602.5(SERPINE1):c.*752C>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000271368] Chr7:101138194 [GRCh38]
Chr7:100781475 [GRCh37]
Chr7:7q22.1
benign|likely benign
NM_000602.5(SERPINE1):c.*1737G>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000307355]|not provided [RCV004712307] Chr7:101139179 [GRCh38]
Chr7:100782460 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.-93C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000328405] Chr7:101127153 [GRCh38]
Chr7:100770434 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1006T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000273570] Chr7:101138448 [GRCh38]
Chr7:100781729 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*207C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000305698] Chr7:101137649 [GRCh38]
Chr7:100780930 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1266G>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000380519] Chr7:101138708 [GRCh38]
Chr7:100781989 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.555G>C (p.Arg185=) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000385823]|not provided [RCV000900725] Chr7:101131924 [GRCh38]
Chr7:100775205 [GRCh37]
Chr7:7q22.1
benign|likely benign
NM_000602.5(SERPINE1):c.*950C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000332163]|not provided [RCV004707167] Chr7:101138392 [GRCh38]
Chr7:100781673 [GRCh37]
Chr7:7q22.1
likely benign|uncertain significance
NM_000602.5(SERPINE1):c.1020C>T (p.Val340=) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000403457]|SERPINE1-related disorder [RCV003950273] Chr7:101135734 [GRCh38]
Chr7:100779015 [GRCh37]
Chr7:7q22.1
likely benign|uncertain significance
NM_000602.5(SERPINE1):c.*1388G>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000404435] Chr7:101138830 [GRCh38]
Chr7:100782111 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*892G>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000277089]|not provided [RCV004712305] Chr7:101138334 [GRCh38]
Chr7:100781615 [GRCh37]
Chr7:7q22.1
benign|likely benign
NM_000602.5(SERPINE1):c.-54C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000383094] Chr7:101127192 [GRCh38]
Chr7:100770473 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.49G>A (p.Val17Ile) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000325357]|not provided [RCV001653713] Chr7:101128442 [GRCh38]
Chr7:100771723 [GRCh37]
Chr7:7q22.1
benign|likely benign
NM_000602.5(SERPINE1):c.456G>C (p.Val152=) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000294811]|not provided [RCV000900882] Chr7:101130605 [GRCh38]
Chr7:100773886 [GRCh37]
Chr7:7q22.1
likely benign|uncertain significance
NM_000602.5(SERPINE1):c.845T>G (p.Ile282Ser) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000337075] Chr7:101133839 [GRCh38]
Chr7:100777120 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*997_*1005dup duplication Congenital plasminogen activator inhibitor type 1 deficiency [RCV000386609] Chr7:101138430..101138431 [GRCh38]
Chr7:100781711..100781712 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.*891C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000362400] Chr7:101138333 [GRCh38]
Chr7:100781614 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.191C>T (p.Ser64Leu) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000389274] Chr7:101128584 [GRCh38]
Chr7:100771865 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.537C>T (p.Ala179=) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000349706]|SERPINE1-related disorder [RCV003922584] Chr7:101131906 [GRCh38]
Chr7:100775187 [GRCh37]
Chr7:7q22.1
likely benign|uncertain significance
NM_000602.5(SERPINE1):c.649G>A (p.Gly217Ser) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000282113] Chr7:101132018 [GRCh38]
Chr7:100775299 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1358T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000340969] Chr7:101138800 [GRCh38]
Chr7:100782081 [GRCh37]
Chr7:7q22.1
benign|likely benign
NM_000602.5(SERPINE1):c.*361T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000341849]|not provided [RCV004712302] Chr7:101137803 [GRCh38]
Chr7:100781084 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.*722T>G single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000366344]|not provided [RCV004712304] Chr7:101138164 [GRCh38]
Chr7:100781445 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.-101G>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000263964] Chr7:101127145 [GRCh38]
Chr7:100770426 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1590A>G single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000347051] Chr7:101139032 [GRCh38]
Chr7:100782313 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1147G>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000319114] Chr7:101138589 [GRCh38]
Chr7:100781870 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1192G>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000334382] Chr7:101138634 [GRCh38]
Chr7:100781915 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*859C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000307771] Chr7:101138301 [GRCh38]
Chr7:100781582 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1784del deletion Congenital plasminogen activator inhibitor type 1 deficiency [RCV000370882] Chr7:101139226 [GRCh38]
Chr7:100782507 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1443C>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000310818] Chr7:101138885 [GRCh38]
Chr7:100782166 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1155T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000373746] Chr7:101138597 [GRCh38]
Chr7:100781878 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1668G>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000393207] Chr7:101139110 [GRCh38]
Chr7:100782391 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*508C>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV000396469] Chr7:101137950 [GRCh38]
Chr7:100781231 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.356dup (p.Ile120fs) duplication Congenital plasminogen activator inhibitor type 1 deficiency [RCV000577798] Chr7:101130504..101130505 [GRCh38]
Chr7:100773785..100773786 [GRCh37]
Chr7:7q22.1
pathogenic|not provided
TMEM106B-BRAF fusion deletion Pleomorphic xanthoastrocytoma [RCV000454357] Chr7:12258147..140494267 [GRCh37]
Chr7:7p21.3-q34
pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:43360-159119707)x1 copy number loss See cases [RCV000446044] Chr7:43360..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
GRCh37/hg19 7q22.1-36.3(chr7:98969247-159119707)x3 copy number gain See cases [RCV000447709] Chr7:98969247..159119707 [GRCh37]
Chr7:7q22.1-36.3
pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:43361-159119707) copy number gain See cases [RCV000510686] Chr7:43361..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:43361-159119707)x3 copy number gain See cases [RCV000511549] Chr7:43361..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000602.5(SERPINE1):c.699_700dup (p.Thr234fs) microsatellite Congenital plasminogen activator inhibitor type 1 deficiency [RCV000577196] Chr7:101132065..101132066 [GRCh38]
Chr7:100775346..100775347 [GRCh37]
Chr7:7q22.1
pathogenic|not provided
Single allele duplication Congenital plasminogen activator inhibitor type 1 deficiency [RCV000677965] Chr7:100730280..100853730 [GRCh37]
Chr7:7q22.1
uncertain significance
GRCh37/hg19 7q22.1(chr7:98847725-102472176)x1 copy number loss not provided [RCV000682904] Chr7:98847725..102472176 [GRCh37]
Chr7:7q22.1
pathogenic
GRCh37/hg19 7q22.1-36.3(chr7:98693388-159119707)x3 copy number gain not provided [RCV000682911] Chr7:98693388..159119707 [GRCh37]
Chr7:7q22.1-36.3
pathogenic
NM_000602.4(SERPINE1):c.0_-2+51del deletion Abnormal bleeding [RCV000852255] Chr7:101127038..101127293 [GRCh38]
Chr7:100770319..100770574 [GRCh37]
Chr7:7q22.1
likely pathogenic
NC_000007.13:g.(20954043_21001537)_(114528369_114556605)inv inversion Childhood apraxia of speech [RCV000234948] Chr7:21001537..114528369 [GRCh37]
Chr7:7p15.3-q31.1
pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:44935-159126310)x3 copy number gain not provided [RCV000746280] Chr7:44935..159126310 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:10704-159122532)x3 copy number gain not provided [RCV000746278] Chr7:10704..159122532 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000602.5(SERPINE1):c.453G>A (p.Glu151=) single nucleotide variant not provided [RCV001532593] Chr7:101130602 [GRCh38]
Chr7:100773883 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.*440T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165142] Chr7:101137882 [GRCh38]
Chr7:100781163 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.*1521T>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165247] Chr7:101138963 [GRCh38]
Chr7:100782244 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.648C>T (p.Asp216=) single nucleotide variant not provided [RCV000947052] Chr7:101132017 [GRCh38]
Chr7:100775298 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.1088-9C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163051]|not provided [RCV000950726] Chr7:101136992 [GRCh38]
Chr7:100780273 [GRCh37]
Chr7:7q22.1
benign|likely benign
GRCh37/hg19 7p22.3-q36.3(chr7:10365-159119707)x3 copy number gain not provided [RCV000848126] Chr7:10365..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000602.5(SERPINE1):c.*533C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165147] Chr7:101137975 [GRCh38]
Chr7:100781256 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*617T>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165149]|not provided [RCV004695074] Chr7:101138059 [GRCh38]
Chr7:100781340 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.816C>A (p.Ala272=) single nucleotide variant not provided [RCV000917112] Chr7:101133810 [GRCh38]
Chr7:100777091 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.*456G>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165144] Chr7:101137898 [GRCh38]
Chr7:100781179 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.91G>A (p.Val31Met) single nucleotide variant not provided [RCV000998867] Chr7:101128484 [GRCh38]
Chr7:100771765 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.163G>A (p.Val55Met) single nucleotide variant not provided [RCV000998869] Chr7:101128556 [GRCh38]
Chr7:100771837 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.469T>C (p.Phe157Leu) single nucleotide variant not provided [RCV000998870]|not specified [RCV004030247] Chr7:101130618 [GRCh38]
Chr7:100773899 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1296G>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163160] Chr7:101138738 [GRCh38]
Chr7:100782019 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1449C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163162]|not provided [RCV004712974] Chr7:101138891 [GRCh38]
Chr7:100782172 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.650G>A (p.Gly217Asp) single nucleotide variant not specified [RCV004286156] Chr7:101132019 [GRCh38]
Chr7:100775300 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.145G>A (p.Ala49Thr) single nucleotide variant not provided [RCV000998868] Chr7:101128538 [GRCh38]
Chr7:100771819 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.1113C>T (p.Ala371=) single nucleotide variant not provided [RCV000998871] Chr7:101137026 [GRCh38]
Chr7:100780307 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.989C>T (p.Thr330Met) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001161523] Chr7:101135583 [GRCh38]
Chr7:100778864 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.421C>T (p.Arg141Trp) single nucleotide variant Thrombus [RCV003313903] Chr7:101130570 [GRCh38]
Chr7:100773851 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.272-243T>C single nucleotide variant not provided [RCV001655949] Chr7:101130178 [GRCh38]
Chr7:100773459 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.*236C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163053] Chr7:101137678 [GRCh38]
Chr7:100780959 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*425T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163056] Chr7:101137867 [GRCh38]
Chr7:100781148 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.-20G>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165028] Chr7:101127226 [GRCh38]
Chr7:100770507 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.149C>G (p.Ser50Cys) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165029] Chr7:101128542 [GRCh38]
Chr7:100771823 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*478A>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165146] Chr7:101137920 [GRCh38]
Chr7:100781201 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1545T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165248] Chr7:101138987 [GRCh38]
Chr7:100782268 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1787T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165249] Chr7:101139229 [GRCh38]
Chr7:100782510 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.357G>A (p.Ala119=) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001158318]|not provided [RCV000889813] Chr7:101130506 [GRCh38]
Chr7:100773787 [GRCh37]
Chr7:7q22.1
benign|likely benign
NM_000602.5(SERPINE1):c.701-45G>A single nucleotide variant not provided [RCV001641946] Chr7:101133650 [GRCh38]
Chr7:100776931 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.900-233_900-222del deletion not provided [RCV001620513] Chr7:101135258..101135269 [GRCh38]
Chr7:100778539..100778550 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.1088-11T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001161525] Chr7:101136990 [GRCh38]
Chr7:100780271 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*1437C>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163161] Chr7:101138879 [GRCh38]
Chr7:100782160 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*180C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163052]|not provided [RCV004707567] Chr7:101137622 [GRCh38]
Chr7:100780903 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.700+10A>G single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001158320] Chr7:101132079 [GRCh38]
Chr7:100775360 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.626G>A (p.Arg209His) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001158319] Chr7:101131995 [GRCh38]
Chr7:100775276 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*661T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001158426] Chr7:101138103 [GRCh38]
Chr7:100781384 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.*685C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001158428]|not provided [RCV004712960] Chr7:101138127 [GRCh38]
Chr7:100781408 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.*863C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001158429] Chr7:101138305 [GRCh38]
Chr7:100781586 [GRCh37]
Chr7:7q22.1
uncertain significance
GRCh37/hg19 7q22.1(chr7:99593346-102470275)x1 copy number loss See cases [RCV001195072] Chr7:99593346..102470275 [GRCh37]
Chr7:7q22.1
likely pathogenic
NM_000602.5(SERPINE1):c.899+93T>C single nucleotide variant not provided [RCV001681942] Chr7:101133986 [GRCh38]
Chr7:100777267 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.506-301A>G single nucleotide variant not provided [RCV001680972] Chr7:101131574 [GRCh38]
Chr7:100774855 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.701-241T>C single nucleotide variant not provided [RCV001614407] Chr7:101133454 [GRCh38]
Chr7:100776735 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.1088-106A>G single nucleotide variant not provided [RCV001663278] Chr7:101136895 [GRCh38]
Chr7:100780176 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.*275C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163054] Chr7:101137717 [GRCh38]
Chr7:100780998 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.-109G>A single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165027] Chr7:101127137 [GRCh38]
Chr7:100770418 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*456G>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165145] Chr7:101137898 [GRCh38]
Chr7:100781179 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*585G>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165148] Chr7:101138027 [GRCh38]
Chr7:100781308 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*294T>G single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001163055] Chr7:101137736 [GRCh38]
Chr7:100781017 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*684T>C single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001158427] Chr7:101138126 [GRCh38]
Chr7:100781407 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.*455C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001165143] Chr7:101137897 [GRCh38]
Chr7:100781178 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.801G>A (p.Glu267=) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001161520] Chr7:101133795 [GRCh38]
Chr7:100777076 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.899+12C>T single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001161521] Chr7:101133905 [GRCh38]
Chr7:100777186 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.934C>T (p.Pro312Ser) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001161522] Chr7:101135528 [GRCh38]
Chr7:100778809 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.995T>C (p.Leu332Pro) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001161524] Chr7:101135589 [GRCh38]
Chr7:100778870 [GRCh37]
Chr7:7q22.1
uncertain significance
GRCh37/hg19 7q22.1(chr7:100685746-100789623)x1 copy number loss not provided [RCV001258813] Chr7:100685746..100789623 [GRCh37]
Chr7:7q22.1
uncertain significance
Single allele complex Ring chromosome 7 [RCV002280646] Chr7:43360..159119707 [GRCh37]
Chr7:7p22.3-q36.3
pathogenic
NM_000602.5(SERPINE1):c.403C>T (p.His135Tyr) single nucleotide variant Hemorrhage [RCV002280953] Chr7:101130552 [GRCh38]
Chr7:100773833 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.713C>T (p.Thr238Met) single nucleotide variant not provided [RCV001310585] Chr7:101133707 [GRCh38]
Chr7:100776988 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.134del (p.Gln45fs) deletion Congenital plasminogen activator inhibitor type 1 deficiency [RCV001333536] Chr7:101128527 [GRCh38]
Chr7:100771808 [GRCh37]
Chr7:7q22.1
pathogenic
NM_000602.5(SERPINE1):c.719A>G (p.Asp240Gly) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV001333537] Chr7:101133713 [GRCh38]
Chr7:100776994 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.74A>C (p.His25Pro) single nucleotide variant not provided [RCV001454287] Chr7:101128467 [GRCh38]
Chr7:100771748 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.506-286A>C single nucleotide variant not provided [RCV001675526] Chr7:101131589 [GRCh38]
Chr7:100774870 [GRCh37]
Chr7:7q22.1
benign
NM_000602.5(SERPINE1):c.149C>T (p.Ser50Phe) single nucleotide variant not provided [RCV001727412] Chr7:101128542 [GRCh38]
Chr7:100771823 [GRCh37]
Chr7:7q22.1
uncertain significance
GRCh37/hg19 7q22.1-31.1(chr7:99417471-111586308) copy number loss not specified [RCV002053711] Chr7:99417471..111586308 [GRCh37]
Chr7:7q22.1-31.1
pathogenic
GRCh37/hg19 7q22.1-31.31(chr7:100676872-119156160) copy number loss not specified [RCV002053712] Chr7:100676872..119156160 [GRCh37]
Chr7:7q22.1-31.31
pathogenic
NC_000007.13:g.(?_98983338)_(100860555_?)del deletion not provided [RCV001877526] Chr7:98983338..100860555 [GRCh37]
Chr7:7q22.1
pathogenic|uncertain significance
NM_000602.5(SERPINE1):c.79C>A (p.Pro27Thr) single nucleotide variant Congenital plasminogen activator inhibitor type 1 deficiency [RCV002245480] Chr7:101128472 [GRCh38]
Chr7:100771753 [GRCh37]
Chr7:7q22.1
uncertain significance
NC_000007.13:g.(?_98507659)_(100860555_?)dup duplication not provided [RCV003113282] Chr7:98507659..100860555 [GRCh37]
Chr7:7q22.1
uncertain significance
GRCh37/hg19 7p22.3-q36.3(chr7:56604613-96692931)x1 copy number loss See cases [RCV002287832] Chr7:56604613..96692931 [GRCh37]
Chr7:7p22.3-q36.3
uncertain significance
NM_000602.5(SERPINE1):c.1172-2A>C single nucleotide variant Gastrointestinal hemorrhage [RCV002280954]|Hemorrhage [RCV003313810] Chr7:101137403 [GRCh38]
Chr7:100780684 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.1172-3C>G single nucleotide variant not provided [RCV002291248] Chr7:101137402 [GRCh38]
Chr7:100780683 [GRCh37]
Chr7:7q22.1
not provided
NM_000602.5(SERPINE1):c.157C>T (p.Arg53Cys) single nucleotide variant not specified [RCV004297165] Chr7:101128550 [GRCh38]
Chr7:100771831 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.509T>C (p.Met170Thr) single nucleotide variant not specified [RCV004102977] Chr7:101131878 [GRCh38]
Chr7:100775159 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.253A>G (p.Met85Val) single nucleotide variant not specified [RCV004137579] Chr7:101128646 [GRCh38]
Chr7:100771927 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.376C>A (p.Leu126Met) single nucleotide variant not specified [RCV004278714] Chr7:101130525 [GRCh38]
Chr7:100773806 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.399G>A (p.Met133Ile) single nucleotide variant not specified [RCV004255832] Chr7:101130548 [GRCh38]
Chr7:100773829 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.1160A>T (p.His387Leu) single nucleotide variant not specified [RCV004353351] Chr7:101137073 [GRCh38]
Chr7:100780354 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.247G>A (p.Ala83Thr) single nucleotide variant not specified [RCV004356689] Chr7:101128640 [GRCh38]
Chr7:100771921 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.497A>T (p.His166Leu) single nucleotide variant not specified [RCV004334724] Chr7:101130646 [GRCh38]
Chr7:100773927 [GRCh37]
Chr7:7q22.1
uncertain significance
GRCh37/hg19 7q22.1(chr7:99114000-101878272)x1 copy number loss not provided [RCV003482971] Chr7:99114000..101878272 [GRCh37]
Chr7:7q22.1
pathogenic
GRCh37/hg19 7q22.1(chr7:100532371-101116321)x3 copy number gain not provided [RCV003484692] Chr7:100532371..101116321 [GRCh37]
Chr7:7q22.1
uncertain significance
GRCh37/hg19 7q22.1(chr7:98396469-102108193)x1 copy number loss not specified [RCV003986701] Chr7:98396469..102108193 [GRCh37]
Chr7:7q22.1
likely pathogenic
GRCh37/hg19 7q22.1(chr7:100454649-101886704)x1 copy number loss not specified [RCV003986697] Chr7:100454649..101886704 [GRCh37]
Chr7:7q22.1
pathogenic
NM_000602.5(SERPINE1):c.114C>T (p.Phe38=) single nucleotide variant SERPINE1-related disorder [RCV003944022] Chr7:101128507 [GRCh38]
Chr7:100771788 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.695A>G (p.Asn232Ser) single nucleotide variant SERPINE1-related disorder [RCV003923876] Chr7:101132064 [GRCh38]
Chr7:100775345 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.957C>T (p.Thr319=) single nucleotide variant not provided [RCV003887513] Chr7:101135551 [GRCh38]
Chr7:100778832 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.217A>G (p.Thr73Ala) single nucleotide variant not specified [RCV004453371] Chr7:101128610 [GRCh38]
Chr7:100771891 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.1114C>G (p.Pro372Ala) single nucleotide variant not provided [RCV004599044] Chr7:101137027 [GRCh38]
Chr7:100780308 [GRCh37]
Chr7:7q22.1
uncertain significance
NC_000007.13:g.(?_94024344)_(100860555_?)del deletion not provided [RCV004578536] Chr7:94024344..100860555 [GRCh37]
Chr7:7q21.3-22.1
pathogenic
NM_000602.5(SERPINE1):c.586G>A (p.Gly196Ser) single nucleotide variant not specified [RCV004667145] Chr7:101131955 [GRCh38]
Chr7:100775236 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.1129A>G (p.Met377Val) single nucleotide variant not specified [RCV004666009] Chr7:101137042 [GRCh38]
Chr7:100780323 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.732C>T (p.Tyr244=) single nucleotide variant not specified [RCV004666008] Chr7:101133726 [GRCh38]
Chr7:100777007 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.616A>G (p.Ser206Gly) single nucleotide variant not specified [RCV004666005] Chr7:101131985 [GRCh38]
Chr7:100775266 [GRCh37]
Chr7:7q22.1
likely benign
NM_000602.5(SERPINE1):c.1157G>A (p.Arg386Gln) single nucleotide variant not specified [RCV004667146] Chr7:101137070 [GRCh38]
Chr7:100780351 [GRCh37]
Chr7:7q22.1
uncertain significance
NM_000602.5(SERPINE1):c.554G>A (p.Arg185Gln) single nucleotide variant not specified [RCV004666006] Chr7:101131923 [GRCh38]
Chr7:100775204 [GRCh37]
Chr7:7q22.1
uncertain significance
miRNA Target Status

Confirmed Target Of
miRNA GeneMature miRNAMethod NameResult TypeData TypeSupport TypePMID
MIR143hsa-miR-143-3pMirtarbaseexternal_infoImmunoblot//Luciferase reporter assay//qRT-PCR//WeFunctional MTI22108519
MIR143hsa-miR-143-3pOncomiRDBexternal_infoNANA22108519
MIR145hsa-miR-145-5pMirtarbaseexternal_infoImmunoblot//Luciferase reporter assay//qRT-PCR//WeFunctional MTI22108519
MIR145hsa-miR-145-5pOncomiRDBexternal_infoNANA22108519
MIR30C2hsa-miR-30c-5pMirtarbaseexternal_infoLuciferase reporter assayFunctional MTI21175428
MIR99Ahsa-miR-99a-5pMirtarbaseexternal_infoLuciferase reporter assayNon-Functional MTI21175428
MIR301Ahsa-miR-301a-3pMirtarbaseexternal_infoLuciferase reporter assayFunctional MTI21175428
MIR30C1hsa-miR-30c-5pMirtarbaseexternal_infoLuciferase reporter assayFunctional MTI21175428

Predicted Target Of
Summary Value
Count of predictions:1778
Count of miRNA genes:627
Interacting mature miRNAs:695
Transcripts:ENST00000223095, ENST00000445463
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCh38)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
407235191GWAS884167_Hblood protein measurement QTL GWAS884167 (human)4e-12blood protein measurementblood protein measurement (CMO:0000028)7101131468101131469Human
407345618GWAS994594_Hplasminogen activator inhibitor 1 measurement QTL GWAS994594 (human)3e-12plasminogen activator inhibitor 1 measurementblood plasminogen activator inhibitor 1 level (CMO:0003034)7101139179101139180Human
407100180GWAS749156_Herythrocyte count QTL GWAS749156 (human)1e-18erythrocyte countred blood cell count (CMO:0000025)7101129564101129565Human
406949640GWAS598616_Htissue plasminogen activator measurement QTL GWAS598616 (human)0.000003tissue plasminogen activator measurement7101131468101131469Human
407055245GWAS704221_Hbody height QTL GWAS704221 (human)2e-14body height (VT:0001253)body height (CMO:0000106)7101129564101129565Human

Markers in Region
D7S477  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,776,761 - 100,776,842UniSTSGRCh37
GRCh377100,776,677 - 100,776,795UniSTSGRCh37
Build 367100,563,397 - 100,563,515RGDNCBI36
Celera795,785,136 - 95,785,217UniSTS
Celera795,785,048 - 95,785,170RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,369,956 - 95,370,037UniSTS
HuRef795,369,868 - 95,369,990UniSTS
CRA_TCAGchr7v27100,135,148 - 100,135,229UniSTS
CRA_TCAGchr7v27100,135,064 - 100,135,182UniSTS
Marshfield Genetic Map7111.79RGD
Genethon Genetic Map7112.3UniSTS
TNG Radiation Hybrid Map744449.0UniSTS
Stanford-G3 RH Map74678.0UniSTS
NCBI RH Map71070.0UniSTS
GeneMap99-G3 RH Map74678.0UniSTS
PLANH1  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,778,837 - 100,778,907UniSTSGRCh37
Build 367100,565,557 - 100,565,627RGDNCBI36
Celera795,787,203 - 95,787,273RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,372,020 - 95,372,090UniSTS
CRA_TCAGchr7v27100,137,224 - 100,137,294UniSTS
Marshfield Genetic Map7111.79UniSTS
G10517  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,782,257 - 100,782,413UniSTSGRCh37
Build 367100,568,977 - 100,569,133RGDNCBI36
Celera795,790,636 - 95,790,792RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,375,455 - 95,375,611UniSTS
CRA_TCAGchr7v27100,140,644 - 100,140,800UniSTS
GDB:4585717  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,777,440 - 100,777,534UniSTSGRCh37
Build 367100,564,160 - 100,564,254RGDNCBI36
Celera795,785,815 - 95,785,909RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,370,635 - 95,370,729UniSTS
CRA_TCAGchr7v27100,135,827 - 100,135,921UniSTS
GDB:201753  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,769,577 - 100,770,467UniSTSGRCh37
Build 367100,556,297 - 100,557,187RGDNCBI36
Celera795,777,941 - 95,778,832RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,362,760 - 95,363,650UniSTS
CRA_TCAGchr7v27100,127,964 - 100,128,854UniSTS
GDB:201866  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,776,627 - 100,776,833UniSTSGRCh37
Build 367100,563,347 - 100,563,553RGDNCBI36
Celera795,784,998 - 95,785,208RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,369,818 - 95,370,028UniSTS
CRA_TCAGchr7v27100,135,014 - 100,135,220UniSTS
RH48262  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,773,768 - 100,773,934UniSTSGRCh37
Build 367100,560,488 - 100,560,654RGDNCBI36
Celera795,782,141 - 95,782,307RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,366,961 - 95,367,127UniSTS
CRA_TCAGchr7v27100,132,155 - 100,132,321UniSTS
GeneMap99-GB4 RH Map7517.07UniSTS
GDB:3755009  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,770,623 - 100,770,749UniSTSGRCh37
Build 367100,557,343 - 100,557,469RGDNCBI36
Celera795,778,988 - 95,779,114RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,363,806 - 95,363,932UniSTS
CRA_TCAGchr7v27100,129,010 - 100,129,136UniSTS
STS-D29544  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,782,307 - 100,782,438UniSTSGRCh37
Build 367100,569,027 - 100,569,158RGDNCBI36
Celera795,790,686 - 95,790,817RGD
Cytogenetic Map7q22.1UniSTS
Cytogenetic Map14q24UniSTS
Cytogenetic Map14q22-q24UniSTS
HuRef795,375,505 - 95,375,636UniSTS
CRA_TCAGchr7v27100,140,694 - 100,140,825UniSTS
GeneMap99-GB4 RH Map7517.07UniSTS
NCBI RH Map71062.2UniSTS
A008P30  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,770,955 - 100,771,145UniSTSGRCh37
Build 367100,557,675 - 100,557,865RGDNCBI36
Celera795,779,320 - 95,779,510RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,364,138 - 95,364,328UniSTS
CRA_TCAGchr7v27100,129,342 - 100,129,532UniSTS
GeneMap99-GB4 RH Map7517.07UniSTS
PAI1  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,769,760 - 100,770,091UniSTSGRCh37
Build 367100,556,480 - 100,556,811RGDNCBI36
Celera795,778,125 - 95,778,456RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,362,943 - 95,363,274UniSTS
CRA_TCAGchr7v27100,128,147 - 100,128,478UniSTS
GDB:512828  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh377100,778,443 - 100,778,769UniSTSGRCh37
Build 367100,565,163 - 100,565,489RGDNCBI36
Celera795,786,818 - 95,787,135RGD
Cytogenetic Map7q22.1UniSTS
HuRef795,371,638 - 95,371,952UniSTS
CRA_TCAGchr7v27100,136,830 - 100,137,156UniSTS
D7S477  
Human AssemblyChrPosition (strand)SourceJBrowse
Cytogenetic Map7q22.1UniSTS


Expression

RNA-SEQ Expression

adipose tissue
alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
entire extraembryonic component
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
pharyngeal arch
renal system
reproductive system
respiratory system
sensory system
visual system
1204 2436 2788 2247 4973 1726 2341 6 624 1903 465 2269 7261 6430 53 3732 1 852 1743 1607 175 1

Sequence

Nucleotide Sequences
RefSeq Transcripts NG_013213 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_000602 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386456 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386457 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386458 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386459 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386460 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386461 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386462 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386463 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386464 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386465 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001386466 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AC004876 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF386492 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AH002922 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AI752990 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK293248 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK297728 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK298048 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK316225 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC005927 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC010860 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC020765 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BF351821 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  C00767 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH471197 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CN309001 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CN309016 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CN309038 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CP068271 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  GN348256 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  HI555467 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  J03764 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M14083 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M16006 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M33136 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  MK468868 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X04429 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X04729 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X04731 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X04744 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X12701 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13338 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13339 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13340 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13341 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13342 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13343 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13344 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13345 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Ensembl Acc Id: ENST00000223095   ⟹   ENSP00000223095
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl7101,127,104 - 101,139,247 (+)Ensembl
RefSeq Acc Id: NM_000602   ⟹   NP_000593
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
GRCh377100,770,370 - 100,782,547 (+)NCBI
Build 367100,557,172 - 100,569,026 (+)NCBI Archive
HuRef795,363,553 - 95,375,745 (+)NCBI
CHM1_17100,700,705 - 100,712,867 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
CRA_TCAGchr7v27100,128,757 - 100,140,934 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386456   ⟹   NP_001373385
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386457   ⟹   NP_001373386
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386458   ⟹   NP_001373387
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386459   ⟹   NP_001373388
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386460   ⟹   NP_001373389
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386461   ⟹   NP_001373390
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386462   ⟹   NP_001373391
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386463   ⟹   NP_001373392
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386464   ⟹   NP_001373393
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386465   ⟹   NP_001373394
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001386466   ⟹   NP_001373395
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,139,247 (+)NCBI
T2T-CHM13v2.07102,449,908 - 102,462,056 (+)NCBI
Sequence:
Protein Sequences
Protein RefSeqs NP_000593 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373385 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373386 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373387 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373388 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373389 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373390 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373391 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373392 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373393 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373394 (Get FASTA)   NCBI Sequence Viewer  
  NP_001373395 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein AAA60003 (Get FASTA)   NCBI Sequence Viewer  
  AAA60007 (Get FASTA)   NCBI Sequence Viewer  
  AAA60008 (Get FASTA)   NCBI Sequence Viewer  
  AAA60009 (Get FASTA)   NCBI Sequence Viewer  
  AAD45828 (Get FASTA)   NCBI Sequence Viewer  
  AAH10860 (Get FASTA)   NCBI Sequence Viewer  
  AAK60338 (Get FASTA)   NCBI Sequence Viewer  
  BAH11475 (Get FASTA)   NCBI Sequence Viewer  
  BAH12656 (Get FASTA)   NCBI Sequence Viewer  
  BAH12712 (Get FASTA)   NCBI Sequence Viewer  
  BAH14596 (Get FASTA)   NCBI Sequence Viewer  
  CAA28025 (Get FASTA)   NCBI Sequence Viewer  
  CAA28438 (Get FASTA)   NCBI Sequence Viewer  
  CAA28442 (Get FASTA)   NCBI Sequence Viewer  
  CAA28444 (Get FASTA)   NCBI Sequence Viewer  
  CAA31208 (Get FASTA)   NCBI Sequence Viewer  
  CAA31722 (Get FASTA)   NCBI Sequence Viewer  
  CAA31729 (Get FASTA)   NCBI Sequence Viewer  
  CAB51606 (Get FASTA)   NCBI Sequence Viewer  
  CAB51607 (Get FASTA)   NCBI Sequence Viewer  
  CAB51639 (Get FASTA)   NCBI Sequence Viewer  
  CAB51737 (Get FASTA)   NCBI Sequence Viewer  
  CAB51738 (Get FASTA)   NCBI Sequence Viewer  
  CAB51739 (Get FASTA)   NCBI Sequence Viewer  
  CAY56481 (Get FASTA)   NCBI Sequence Viewer  
  CBX47312 (Get FASTA)   NCBI Sequence Viewer  
  EAW50195 (Get FASTA)   NCBI Sequence Viewer  
  EAW50196 (Get FASTA)   NCBI Sequence Viewer  
  EAW50197 (Get FASTA)   NCBI Sequence Viewer  
Ensembl Protein ENSP00000223095
  ENSP00000223095.4
GenBank Protein P05121 (Get FASTA)   NCBI Sequence Viewer  
  QEG78876 (Get FASTA)   NCBI Sequence Viewer  
RefSeq Acc Id: NP_000593   ⟸   NM_000602
- Peptide Label: isoform 2 precursor
- UniProtKB: B7Z4S0 (UniProtKB/Swiss-Prot),   F8WD53 (UniProtKB/Swiss-Prot),   P05121 (UniProtKB/Swiss-Prot),   B7Z4X6 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSP00000223095   ⟸   ENST00000223095
RefSeq Acc Id: NP_001373395   ⟸   NM_001386466
- Peptide Label: isoform 12 precursor
- UniProtKB: B7Z4X6 (UniProtKB/TrEMBL)
RefSeq Acc Id: NP_001373394   ⟸   NM_001386465
- Peptide Label: isoform 11 precursor
- UniProtKB: B7Z4X6 (UniProtKB/TrEMBL)
RefSeq Acc Id: NP_001373387   ⟸   NM_001386458
- Peptide Label: isoform 5 precursor
- UniProtKB: B7Z4X6 (UniProtKB/TrEMBL)
RefSeq Acc Id: NP_001373393   ⟸   NM_001386464
- Peptide Label: isoform 10 precursor
RefSeq Acc Id: NP_001373388   ⟸   NM_001386459
- Peptide Label: isoform 6 precursor
RefSeq Acc Id: NP_001373389   ⟸   NM_001386460
- Peptide Label: isoform 1 precursor
RefSeq Acc Id: NP_001373390   ⟸   NM_001386461
- Peptide Label: isoform 7 precursor
RefSeq Acc Id: NP_001373386   ⟸   NM_001386457
- Peptide Label: isoform 4 precursor
RefSeq Acc Id: NP_001373392   ⟸   NM_001386463
- Peptide Label: isoform 9 precursor
- UniProtKB: B7Z4X6 (UniProtKB/TrEMBL)
RefSeq Acc Id: NP_001373391   ⟸   NM_001386462
- Peptide Label: isoform 8
- UniProtKB: B7ZAB0 (UniProtKB/TrEMBL),   B7Z4X6 (UniProtKB/TrEMBL)
RefSeq Acc Id: NP_001373385   ⟸   NM_001386456
- Peptide Label: isoform 3
- UniProtKB: B7Z4X6 (UniProtKB/TrEMBL)
Protein Domains
SERPIN

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P05121-F1-model_v2 AlphaFold P05121 1-402 view protein structure

Promoters
RGD ID:6805274
Promoter ID:HG_KWN:59013
Type:Non-CpG
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:K562
Transcripts:NM_001165413,   OTTHUMT00000347458,   OTTHUMT00000347459,   UC003UXS.2
Position:
Human AssemblyChrPosition (strand)Source
Build 367100,556,791 - 100,557,291 (+)MPROMDB
RGD ID:7211437
Promoter ID:EPDNEW_H11465
Type:initiation region
Name:SERPINE1_2
Description:serpin family E member 1
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H11466  
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,126,887 - 101,126,947EPDNEW
RGD ID:7211443
Promoter ID:EPDNEW_H11466
Type:initiation region
Name:SERPINE1_1
Description:serpin family E member 1
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Alternative Promoters:null; see alsoEPDNEW_H11465  
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh387101,127,104 - 101,127,164EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:8583 AgrOrtholog
COSMIC SERPINE1 COSMIC
Ensembl Genes ENSG00000106366 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000223095 ENTREZGENE
  ENST00000223095.5 UniProtKB/Swiss-Prot
Gene3D-CATH 2.30.39.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  3.30.497.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
GTEx ENSG00000106366 GTEx
HGNC ID HGNC:8583 ENTREZGENE
Human Proteome Map SERPINE1 Human Proteome Map
InterPro Serpin_CS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Serpin_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Serpin_fam UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Serpin_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Serpin_sf_1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Serpin_sf_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report hsa:5054 UniProtKB/Swiss-Prot
NCBI Gene 5054 ENTREZGENE
OMIM 173360 OMIM
PANTHER PLASMINOGEN ACTIVATOR INHIBITOR 1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  PTHR11461 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Serpin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB PA261 PharmGKB, RGD
PROSITE SERPIN UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
SMART SERPIN UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP SSF56574 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt B7Z4S0 ENTREZGENE
  B7Z4X6 ENTREZGENE, UniProtKB/TrEMBL
  B7ZAB0 ENTREZGENE, UniProtKB/TrEMBL
  F8WD53 ENTREZGENE
  P05121 ENTREZGENE, UniProtKB/Swiss-Prot
UniProt Secondary B7Z4S0 UniProtKB/Swiss-Prot
  F8WD53 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-04-12 SERPINE1  serpin family E member 1  SERPINE1  serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1  Symbol and/or name change 5135510 APPROVED